Stericidal composition

Abstract

A fungicidal composition comprising a mixture of components (A) and (B) as defined in claim 1 and the use of the composition in agriculture or horticulture for controlling or preventing infection of plants by phytopathogenic microorganisms, preferably fungi.

Description

[Technical field]

[0001] The present invention relates to novel fungicidal compositions, their use in agriculture or horticulture for controlling diseases caused by plant pathogens, in particular by phytopathogenic fungi, and to methods for controlling diseases of useful plants. [Background technology]

[0002] WO 2010 / 012793, WO 2017 / 207362 and WO 2019 / 105933, WO 2020 / 109509, WO 2020 / 109511 and WO 2020 / 193618 describe thiazole derivatives as pesticides. Summary of the Invention [Problem to be solved by the invention]

[0003] Although many fungicidal compounds and compositions belonging to various different chemical classes have been developed and are being developed for use as fungicides in useful plant crops, the crop resistance and activity against specific plant pathogens do not always meet the needs of agricultural practice in many respects. Therefore, there is a continuing need to find new compounds and compositions with superior biological properties for use in controlling or preventing plant infection by plant pathogens. For example, compounds with greater biological activity, advantageous spectrum of activity, increased stability profile, improved physicochemical properties, increased biodegradability, or compositions with broader activity spectrum, improved crop resistance, synergistic interactions or enhancing properties, or compositions that show a more rapid onset of action or have a longer lasting residual activity, or that allow for reduced application times and / or reduced application rates of compounds and compositions required for effective control of plant pathogens, thereby allowing for beneficial resistance management practices, reduced environmental impact and reduced worker exposure. [Means for solving the problem]

[0004] Compositions containing mixtures of different fungicidal compounds with different mechanisms of action can be used to meet some of these demands (e.g., by combining fungicides with different spectra of activity).

[0005] According to the present invention, there is provided a fungicidal composition comprising as active ingredients a mixture of components (A) and (B), wherein component (A) is a compound represented by formula (I): [ka] (In the formula, A is CH or N; R 1 is C 1 ~C 4 Alkoxy C 1 ~C 2 Alkyl, C 1 ~C 6 Alkyl Sulfanyl C 1 ~C 6 Alkyl, C 1 ~C 6 Alkyl Sulfinyl C 1 ~C 6 Alkyl, C 1 ~C 6 Alkyl Sulfonyl C 1 ~C 6 alkyl or heterocyclyl, wherein the heterocyclyl moiety is a 4-, 5-, or 6-membered non-aromatic monocyclic ring containing 1, 2, or 3 heteroatoms independently selected from nitrogen, oxygen, and sulfur; R 2 is hydrogen or halogen; R 3 is C 1 ~C 8 is alkyl; R 4 , R 5 , R 6 are each independently hydrogen or C 1 ~C 4 is alkyl; R 7 is hydrogen, C 1 ~C 4 Alkyl, C1 ~C 6 Alkoxycarbonyl C 1 ~C 4 Alkyl, C 1 ~C 6 Alkoxycarbonyl or C 1 ~C 6 is alkoxy; R 8 is hydrogen, C 1 ~C 6 Alkoxy C 1 ~C 6 Alkyl carbonyl, C 1 ~C 6 Alkyl Sulfanyl C 1 ~C 6 Alkyl carbonyl, C 1 ~C 6 Alkyl Sulfinyl C 1 ~C 6 Alkyl carbonyl, C 1 ~C 6 Alkyl Sulfonyl C 1 ~C 6 alkylcarbonyl or heterocyclylcarbonyl, where the heterocyclyl moiety is a 4-, 5-, or 6-membered non-aromatic monocyclic ring containing 1, 2, or 3 heteroatoms independently selected from nitrogen, oxygen, and sulfur. or a salt or N-oxide thereof; and Ingredient (B) is azoxystrobin, trifloxystrobin, pyraclostrobin, picoxystrobin, cumoxystrobin, methyltetraprole, cyproconazole, tebuconazole, difenoconazole, hexaconazole, propiconazole, fenhexamid, prothioconazole, mefentrifluconazole, prochloraz, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumet Fen, isoflucipram, bixafen, penthiopyrad, impirfluxam, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, trinexapac-ethyl, fosetylaluminum, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tebuflo quinone, tolprocarb, tricyclazole, pyroquilon, cyflufenamid, metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine (this compound can be prepared from the method described in WO 2016 / 202742); N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine (this compound can be prepared from the method described in WO 2016 / 2026 88); N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide (these compounds can be prepared from the methods described in WO 2017 / 153380);1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline (these compounds are disclosed in International Publication No. WO 2017 / 023363). 5510; 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline (these compounds can be prepared from the method described in WO 2005 / 023362); 2016 / 156085); N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine (these compounds can be prepared from the methods described in WO 2015 / 155075); N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine (these compounds can be prepared from the methods described in WO 2018 / 228896);N-Methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-Methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-Dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl ]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine (these compounds can be prepared from the methods described in WO 2017 / 055473, WO 2017 / 055469, WO 2017 / 093348 and WO 2017 / 118689);Methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, Methyl (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate (these compounds can be prepared from the method described in WO 2020 / 079111); methyl (Z)-2-(5-cyclohexyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy] methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, TAEGRO® (i.e., Bacillus amyloliquefaciens strain FZB24), tea tree oil (extract of the tea tree plant Melaleuca alternifolia (commercially available as Timorex Gold®, a broad-spectrum botanical biofungicide)) and methallyl picoxamide;

[0006] In general, the weight ratio of component (A) to component (B) may preferably be from 100:1 to 1:100, from 50:1 to 1:50, from 20:1 to 1:40, from 15:1 to 1:30, from 12:1 to 1:25, from 10:1 to 1:20, from 5:1 to 1:15, from 3:1 to 1:10, or from 2:1 to 1:5.

[0007] In one embodiment, the weight ratio of component (A) to component (B) may preferably be from 50:1 to 1:5, from 33.3 to 1:1, from 10:1 to 1:1, or from 3.3:1 to 1:1.

[0008] Furthermore, according to the present invention there is provided a method for controlling or preventing phytopathogenic diseases, in particular phytopathogenic fungi, in useful plants or their propagation material, which comprises applying to the useful plants, their habitat or their propagation material a fungicidal composition according to the present invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0009] The benefits provided by certain fungicidal mixture compositions according to the invention may include, in particular, advantageous levels of biological activity for protecting plants from diseases caused by fungi or superior properties for use as pesticide active ingredients (e.g., high biological activity, advantageous activity spectrum, increased safety profile, improved physicochemical properties or increased biodegradability).

[0010] The presence of one or more possible asymmetric carbon atoms in the compounds of formula (I) means that the compounds can exist in the form of optical isomers, i.e. enantiomers or diastereomers. As a result of restricted rotation around single bonds, atropisomers can also occur. Formula (I) is intended to include all these possible isomeric forms and mixtures thereof. The present invention includes all these possible isomeric forms and mixtures thereof for the compounds of formula (I). Similarly, formula (I) is intended to include all possible tautomers. The present invention includes all possible tautomeric forms for the compounds of formula (I). In each case, the compounds of formula (I) according to the invention are in free form, in oxidized form as N-oxides or in salt form, for example in agriculturally usable salt form. N-oxides are the oxidized form of tertiary amines or the oxidized form of nitrogen-containing aromatic heterocyclic compounds. These are described, for example, in the book "Heterocyclic N-oxides", A. Albini and S. Pietra, CRC Press, Boca Raton 1991.

[0011] As used herein, the term "halogen" refers to fluorine (fluoro), chlorine (chloro), bromine (bromo) or iodine (iodo).

[0012] As used herein, "C 1 ~C 8 The term "alkyl" refers to a straight or branched hydrocarbon chain radical consisting solely of carbon and hydrogen atoms, containing no unsaturation, having from 1 to 8 carbon atoms, and attached to the remainder of the molecule by a single bond. 1 ~C 6 Alkyl, C 1 ~C 4 Alkyl" and "C 1 ~C 3 "Alkyl" should be construed accordingly. 1 ~C 8 Examples of alkyl include, but are not limited to, methyl, ethyl, n-propyl and its isomers such as isopropyl. 1 ~C 6An "alkylene" group has the same structure as C, except that the group is attached to the remainder of the molecule by two single bonds. 1 ~C 6 Refers to the corresponding definition of alkyl.

[0013] As used herein, "C 1 ~C 6 The term "alkoxy" refers to a group of the formula -OR a (In the formula, R a is C as generally defined above 1 ~C 6 "C" refers to the group of the alkyl group. 1 ~C 4 Alkoxy" and "C 1 ~C 3 The term "alkoxy" should be construed accordingly. 1 ~C 6 Examples of alkoxy include, but are not limited to, methoxy, ethoxy, 1-methylethoxy (isopropoxy), and propoxy.

[0014] As used herein, "C 1 ~C 6 Alkoxy C 1 ~C 6 The term "alkyl" refers to a group of the formula R b OR a -(In the formula, R b is C as generally defined above 1 ~C 6 is an alkyl group, and R a is C as generally defined above 1 ~C 6 "C" refers to the group of alkylene groups. 1 ~C 6 Alkoxy C 1 ~C 6 Alkyl, C 1 ~C 4 Alkoxy C 1 ~C 4 Alkyl, C 1 ~C 4 Alkoxy C 1 ~C 3 Alkyl, C1 ~C 4 Alkoxy C 1 ~C 2 Alkyl" and "C 3 ~C 4 Alkoxy C 1 ~C 2 "Alkyl" should be construed accordingly. 1 ~C 6 Alkoxy C 1 ~C 6 Examples of alkyl include, but are not limited to, isopropoxymethyl, tert-butoxymethyl, 1-methoxyethyl, 1-isopropoxyethyl, and 1-tert-butoxyethyl.

[0015] As used herein, "C 1 ~C 6 The term "alkoxycarbonyl" refers to a group of the formula R a OC(O)-(wherein, R a is C as generally defined above 1 ~C 6 "C" refers to the group of the alkyl group. 1 ~C 4 Alkoxycarbonyl" and "C 1 ~C 3 "Alkoxycarbonyl" should be construed accordingly.

[0016] As used herein, "C 1 ~C 6 Alkoxycarbonyl C 1 ~C 4 The term "alkyl" refers to a group of the formula R a O.C.(O)R b -(In the formula, R a is C as generally defined above 1 ~C 6 is an alkyl group, and R b is C as generally defined above 1 ~C 4 It refers to the group (which is an alkylene group).

[0017] As used herein, "C 1~C 6 Alkoxy C 1 ~C 6 The term "alkylcarbonyl" refers to a group of the formula R a OR b C(O)-(wherein, R a is C as generally defined above 1 ~C 6 is an alkyl group, and R b is C as generally defined above 1 ~C 6 It refers to the group (which is an alkylene group).

[0018] As used herein, "C 1 ~C 6 Alkyl Sulfanyl C 1 ~C 6 The term "alkyl" refers to a group of the formula R a S.R. b -(In the formula, R a is C as generally defined above 1 ~C 6 is an alkyl group, and R b is C as generally defined above 1 ~C 6 It refers to the group (which is an alkylene group).

[0019] As used herein, "C 1 ~C 6 Alkyl Sulfinyl C 1 ~C 6 The term "alkyl" refers to a group of the formula R a S(O)R b -(In the formula, R a is C as generally defined above 1 ~C 6 is an alkyl group, and R b is C as generally defined above 1 ~C 6 It refers to the group (which is an alkylene group).

[0020] As used herein, "C 1 ~C 6 Alkyl Sulfanyl C 1~C 6 The term "alkylcarbonyl" refers to a group of the formula R a S.R. b C(O)-(wherein, R a is C as generally defined above 1 ~C 6 is an alkyl group, and R b is C as generally defined above 1 ~C 6 It refers to the group (which is an alkylene group).

[0021] As used herein, "C 1 ~C 6 Alkyl Sulfinyl C 1 ~C 6 The term "alkylcarbonyl" refers to a group of the formula R a S(O)R b C(O)-(wherein, R a is C as generally defined above 1 ~C 6 is an alkyl group, and R b is C as generally defined above 1 ~C 6 It refers to the group (which is an alkylene group).

[0022] As used herein, "C 1 ~C 6 Alkyl Sulfonyl C 1 ~C 6 The term "alkylcarbonyl" refers to a group of the formula R a S(O) 2 R b C(O)-(wherein, R a is C as generally defined above 1 ~C 6 is an alkyl group, and R b is C as generally defined above 1 ~C 6 It refers to the group (which is an alkylene group).

[0023] As used herein, the term "heterocyclyl" refers to a stable 4-, 5-, or 6-membered non-aromatic monocyclic ring containing one, two, or three heteroatoms, each heteroatom being independently selected from nitrogen, oxygen, and sulfur. The heterocyclyl group may be attached to the remainder of the molecule via a carbon atom or a heteroatom. Examples of heterocyclyl include, but are not limited to, aziridinyl, azetidinyl, oxetanyl, thietanyl, tetrahydrofuryl, pyrrolidinyl, pyrazolidinyl, imidazolidinyl, piperidinyl, piperazinyl, morpholinyl, dioxolanyl, dithiolanyl, and thiazolidinyl.

[0024] As used herein, the term “heterocyclylcarbonyl” refers to a heterocyclyl group of formula R a C(O)-(wherein, R a refers to the group: wherein R is a heterocyclyl moiety as defined above.

[0025] Preferred groups and values ​​of the substituents in the compounds of formula (I) are as follows, in any combination thereof: A is CH or N. In one set of embodiments, A is CH. In another set of embodiments, A is N.

[0026] R 1 is C 1 ~C 4 Alkoxy C 1 ~C 2 Alkyl, C 1 ~C 6 Alkyl Sulfanyl C 1 ~C 6 Alkyl, C 1 ~C 6 Alkyl Sulfinyl C 1 ~C 6 Alkyl, C 1 ~C 6 Alkyl Sulfonyl C 1 ~C 6 alkyl or heterocyclyl, where the heterocyclyl moiety is a 4-, 5- or 6-membered non-aromatic monocyclic ring containing 1, 2 or 3 heteroatoms independently selected from nitrogen, oxygen and sulfur.1 is C 1 ~C 4 Alkoxy C 1 ~C 2 Alkyl, C 1 ~C 3 Alkyl Sulfanyl C 1 ~C 3 Alkyl, C 1 ~C 3 Alkyl Sulfinyl C 1 ~C 3 Alkyl, C 1 ~C 3 Alkyl Sulfonyl C 1 ~C 3 alkyl or heterocyclyl, where the heterocyclyl moiety is a 4-, 5- or 6-membered non-aromatic monocyclic ring containing 1 or 2 heteroatoms independently selected from nitrogen and oxygen. More preferably, R 1 is C 1 ~C 3 Alkoxy C 1 ~C 2 Alkyl, C 1 ~C 3 Alkyl Sulfanyl C 1 ~C 3 Alkyl, C 1 ~C 3 Alkyl Sulfinyl C 1 ~C 3 Alkyl, C 1 ~C 3 Alkyl Sulfonyl C 1 ~C 3 alkyl or heterocyclyl, the heterocyclyl moiety being a 4-, 5- or 6-membered non-aromatic monocyclic ring containing a single oxygen atom. Even more preferably, R 1 is C 3 ~C 4 Alkoxy C 1 ~C 2 Alkyl, C 1 ~C 3 Alkyl Sulfanyl C 1 ~C 3 Alkyl, C 1 ~C 3 Alkyl Sulfinyl C 1 ~C 3 Alkyl, C 1 ~C3 Alkyl Sulfonyl C 1 ~C 3 alkyl or heterocyclyl, where the heterocyclyl moiety is a 4-, 5- or 6-membered non-aromatic monocyclic ring containing 1 or 2 heteroatoms independently selected from nitrogen and oxygen. Even more preferably, R 1 isopropoxymethyl, tert-butoxymethyl, 1-methoxyethyl, 1-isopropoxyethyl, 1-tert-butoxyethyl, C 1 ~C 3 Alkyl Sulfanyl C 1 ~C 3 Alkyl, C 1 ~C 3 Alkyl Sulfinyl C 1 ~C 3 Alkyl, C 1 ~C 3 Alkyl Sulfonyl C 1 ~C 3 In a further preferred embodiment, R is an alkyl or heterocyclyl, the heterocyclyl moiety being a 4-, 5-, or 6-membered non-aromatic monocyclic ring containing 1 or 2 heteroatoms independently selected from nitrogen and oxygen. 1 is isopropoxymethyl, tert-butoxymethyl, 1-methoxyethyl, 1-isopropoxyethyl, 1-tert-butoxyethyl, 1-methylsulfonylethyl, oxetan-3-yl, tetrahydrofuran-2-yl, tetrahydrofuran-3-yl or tetrahydropyran-4-yl.

[0027] R 2 is hydrogen or halogen. Preferably, R 2 is hydrogen, chloro or fluoro. More preferably, R 2 is fluoro.

[0028] R 3 is C 1 ~C 8 Preferably, R 3 is C 1 ~C 6 Alkyl, more preferably C 1 ~C 3Even more preferably, R 3 is methyl.

[0029] R 4 , R 5 , R 6 are each independently hydrogen or C 1 ~C 4 Preferably, R 4 , R 5 , R 6 are each independently hydrogen or C 1 ~C 3 More preferably, R 4 , R 5 , R 6 are each independently hydrogen or methyl. In one set of embodiments, R 4 , R 5 , R 6 are all hydrogen. In another set of embodiments, R 4 is hydrogen and R 5 and R 6 are both methyl.

[0030] R 7 is hydrogen, C 1 ~C 4 Alkyl, C 1 ~C 6 Alkoxycarbonyl C 1 ~C 4 Alkyl, C 1 ~C 6 Alkoxycarbonyl or C 1 ~C 6 Preferably, R 7 is hydrogen, C 1 ~C 4 Alkyl, C 1 ~C 4 Alkoxycarbonyl C 1 ~C 2 Alkyl, C 1 ~C 3 Alkoxycarbonyl or C 1 ~C 3 More preferably, R 7is hydrogen, methyl, methoxycarbonylmethyl, methoxycarbonyl, or methoxy. In one set of embodiments, R 7 is hydrogen.

[0031] R 8 is hydrogen, C 1 ~C 6 Alkoxy C 1 ~C 6 Alkyl carbonyl, C 1 ~C 6 Alkyl Sulfanyl C 1 ~C 6 Alkyl carbonyl, C 1 ~C 6 Alkyl Sulfinyl C 1 ~C 6 Alkyl carbonyl, C 1 ~C 6 Alkyl Sulfonyl C 1 ~C 6 alkylcarbonyl or heterocyclylcarbonyl, where the heterocyclyl moiety is a 4-, 5- or 6-membered non-aromatic monocyclic ring containing 1, 2 or 3 heteroatoms independently selected from nitrogen, oxygen and sulfur. 8 is hydrogen, C 1 ~C 4 Alkoxy C 1 ~C 4 Alkyl carbonyl, C 1 ~C 4 Alkyl Sulfanyl C 1 ~C 4 Alkyl carbonyl, C 1 ~C 4 Alkyl Sulfinyl C 1 ~C 4 Alkyl carbonyl, C 1 ~C 4 Alkyl Sulfonyl C 1 ~C 4 alkylcarbonyl or heterocyclylcarbonyl, where the heterocyclyl moiety is a 4-, 5- or 6-membered non-aromatic monocyclic ring containing 1 or 2 heteroatoms independently selected from nitrogen, oxygen and sulfur. More preferably, R 8 is hydrogen, C 1 ~C 3 Alkoxy C1 ~C 3 Alkyl carbonyl, C 1 ~C 3 Alkyl Sulfanyl C 1 ~C 3 Alkyl carbonyl, C 1 ~C 3 Alkyl Sulfinyl C 1 ~C 3 Alkyl carbonyl, C 1 ~C 3 Alkyl Sulfonyl C 1 ~C 3 alkylcarbonyl or heterocyclylcarbonyl, where the heterocyclyl moiety is a 4- or 5-membered non-aromatic monocyclic ring containing 1 or 2 heteroatoms independently selected from nitrogen and oxygen.

[0032] Even more preferably, R 8 is hydrogen or heterocyclylcarbonyl, the heterocyclyl moiety being a 4- or 5-membered non-aromatic monocyclic ring containing a single oxygen atom. Even more preferably, R 8 is hydrogen or tetrahydrofuran-3-carbonyl. Most preferably, R 8 is hydrogen.

[0033] Preferably, component (A) is one of the following compounds as defined in Table X below: 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-N-(tetrahydrofuran-3-carbonyl)thiazole-4-carboxamide (compound X.01); 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-2-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.02); 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.03); 2-[(2,6-difluoro-4-pyridyl)-(oxetane-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.04); 2-[2-tert-butoxypropanoyl-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.05); 2-[(2,6-difluoro-4-pyridyl)-(2-isopropoxypropanoyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.06); 2-[(2-tert-butoxyacetyl)-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.07); 2-[(2,6-difluoro-4-pyridyl)-(2-isopropoxyacetyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.08); 2-[(2,6-difluoro-4-pyridyl)-(2-methoxypropanoyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.09); 2-[(2,6-difluoro-4-pyridyl)-(2-methylsulfonylpropanoyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.10); and 2-[(2,6-difluoro-4-pyridyl)-(tetrahydropyran-4-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.11) or one of its (S)- or (R)-enantiomers.

[0034] More preferably, component (A) is as defined in Table X below: 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-2-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.02); 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.03); 2-[(2,6-difluoro-4-pyridyl)-(oxetane-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.04); 2-[2-tert-butoxypropanoyl-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.05); 2-[(2-tert-butoxyacetyl)-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.07); 2-[(2,6-difluoro-4-pyridyl)-(2-methoxypropanoyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.09); and 2-[(2,6-difluoro-4-pyridyl)-(tetrahydropyran-4-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.11) or one of its (S)- or (R)-enantiomers.

[0035] Even more preferably, component (A) is as defined in Table X below: 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-2-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.02); 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.03); 2-[(2,6-difluoro-4-pyridyl)-(oxetane-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.04); and 2-[(2,6-difluoro-4-pyridyl)-(tetrahydropyran-4-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.11) or one of its (S)- or (R)-enantiomers.

[0036] [Table 1-1] [Table 1-2] [Table 1-3] [Table 1-4]

[0037] Preferably, component (B) is azoxystrobin, trifloxystrobin, pyraclostrobin, picoxystrobin, cumoxystrobin, methyltetraprole, cyproconazole, tebuconazole, difenoconazole, hexaconazole, propiconazole, fenhexamid, prothioconazole, mefentrifluconazole, prochloraz, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflucipram, bixafen. , penthiopyrad, impirfluxam, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, trinexapac-ethyl, fosetylaluminum, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tebufloquine, tolprocarb, tricyclazole, pyroquilon, cyflufenamid, metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-ene 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-Dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]- N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecal Voxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoro 3-Ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-Ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, Ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, N,N-Dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy] methyl (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoate; methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate; methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3 -Methoxy-prop-2-enoate, methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]-3- The compound is selected from the group consisting of methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, TAEGRO® (i.e., Bacillus amyloliquefaciens strain FZB24), tea tree oil (extract of the tea tree plant Melaleuca alternifolia (commercially available as Timorex Gold®, a broad-spectrum botanical biofungicide)) and methallyl picoxamide.

[0038] More preferably, component (B) is selected from the group consisting of azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflutipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methionine, , chlorothalonil, mancozeb, mandipropamid, oxathiapiprolin, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, cyflufenamid, metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-tri ... 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine N-isopropyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4 -oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, -yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate; methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate; methyl (Z)-2-(5-cyclohexyl-2-methyl)prop-2-enoate; methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl] The compound is selected from the group consisting of methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate and methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate.

[0039] Even more preferably, component (B) is selected from the group consisting of azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflucipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, N-(1 4,4-Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline.

[0040] In one set of embodiments, component (B) is selected from the group consisting of azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, bixafen, isoflucipram, isofetamide, pi Lapropoin, Fluindapyr, Fenpicoxamide, Florylpicoxamide, Methallylpicoxamide, Chlorothalonil, Mancozeb, Mandipropamide, Oxathiapiproline, Fluazinam, Fludioxonil, Cyprodinil, Metalaxyl-M, Aminopyrifen, Folpet, Ipflufenoquin, Quinofumelin, Tricyclazole, Pyroquilon, Acibenzolar-S-methyl, Cyflufenamid, Metrafenone, Fluazinam , Fosetyl-aluminum, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl- The compound is selected from the group consisting of 1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, TAEGRO®, and tea tree oil (extract of the tea tree plant Melaleuca alternifolia (commercially available as Timorex Gold®, a broad spectrum botanical biofungicide)).

[0041] In a particularly preferred set of embodiments, component (B) is selected from the group consisting of azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflucipram, isofetamide. , pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, chlorothalonil, mancozeb, mandipropamid, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzyl 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-Trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, TAEGRO®, tea tree oil (extract of the tea tree plant Melaleuca alternifolia (commercially available as Timorex Gold®, a broad-spectrum botanical biofungicide)), acibenzolar-S-methyl, cyflufenamid, metrafenone, fosetyl-aluminum, methallyl picoxamide, methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, methyl Methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, Methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, Methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, Methyl (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4 -oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea and ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate.

[0042] The compounds of component (B) are referred to herein above by the so-called "ISO common names" or other "common names" or trade names used in individual cases. The compounds of component (B) are known, commercially available, and / or can be prepared using procedures known in the art and / or reported in the literature.

[0043] In a preferred composition according to the invention, component (A) is compound number X.01, 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-N-(tetrahydrofuran-3-carbonyl)thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothiazole, tetrahydrofuran-4-carbonyl ... Oconazole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isofulcipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufe Nokin, quinofumelin, tricyclazole, pyroquilon, cyflufenamid, metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline,1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4- [5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate,N,N-Dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine, Methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, Methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, Methyl Methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate, methyl (Z)-2-(5-cyclohexyl methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]-3-methoxy-prop The compound is selected from the group consisting of methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, bixafen, fosetyl-aluminum, TAEGRO®, tea tree oil (extract of the tea tree plant Melaleuca alternifolia (commercially available as Timorex Gold®, a broad spectrum botanical biofungicide)) and methallyl picoxamide, and the weight ratio of component (A) to component (B) is from 15:1 to 1:30. In a preferred embodiment, the composition comprisesThe composition comprises the (S)-enantiomer of compound X.01 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.01 or a salt or N-oxide thereof.

[0044] In another preferred composition according to the invention, component (A) is compound number X.02, 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-2-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrif Leuconazole, fenpropizin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflucipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin , tricyclazole, pyroquilon, cyflufenamid, metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3 -carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline,1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4- [5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate,N,N-Dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine, Methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, Methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, Methyl Methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate, methyl (Z)-2-(5-cyclohexyl methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoate The compound is selected from the group consisting of methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, bixafen, fosetyl aluminum, TAEGRO®, tea tree oil (extract of the tea tree plant Melaleuca alternifolia (commercially available as Timorex Gold®, a broad spectrum botanical biofungicide)) and methallyl picoxamide, and the weight ratio of component (A) to component (B) is from 15:1 to 1:30. In a preferred embodiment, the composition isThe composition comprises the (S)-enantiomer of compound X.02 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.02 or a salt or N-oxide thereof.

[0045] In another preferred composition according to the invention, component (A) is compound number X.03, 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrif Leuconazole, fenpropizin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflucipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin , tricyclazole, pyroquilon, cyflufenamid, metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3 -carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline,1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4- [5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate,N,N-Dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine, Methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, Methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, Methyl Methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate, methyl (Z)-2-(5-cyclohexyl methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]-3-methoxy-prop The compound is selected from the group consisting of methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, bixafen, fosetyl-aluminum, TAEGRO®, tea tree oil (extract of the tea tree plant Melaleuca alternifolia (commercially available as Timorex Gold®, a broad spectrum botanical biofungicide)) and methallyl picoxamide, and the weight ratio of component (A) to component (B) is from 15:1 to 1:30. In a preferred embodiment, the composition comprisesThe composition comprises the (S)-enantiomer of compound X.03 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.03 or a salt or N-oxide thereof.

[0046] In another preferred composition according to the invention, component (A) is compound number X.04, 2-[(2,6-difluoro-4-pyridyl)-(oxetane-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrifluconazole, zole, fenpropizin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflucipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, thoraxol Lycyclazole, Pyroquilon, Cyflufenamid, Metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3- Carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline,1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4- [5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate,N,N-Dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine, Methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, Methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, Methyl Methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate, methyl (Z)-2-(5-cyclohexyl methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]-3-methoxy-prop The compound is selected from the group consisting of methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, bixafen, fosetyl-aluminum, TAEGRO®, tea tree oil (extract of the tea tree plant Melaleuca alternifolia (commercially available as Timorex Gold®, a broad spectrum botanical biofungicide)) and methallyl picoxamide, and the weight ratio of component (A) to component (B) is from 15:1 to 1:30. In a preferred embodiment, the composition comprisesThe composition comprises the (S)-enantiomer of compound X.04 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.04 or a salt or N-oxide thereof.

[0047] In another preferred composition according to the invention, component (A) is compound number X.05, 2-[2-tert-butoxypropanoyl-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentriflucoside, Nazole, fenpropizin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflucipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, Tricyclazole, Pyroquilon, Cyflufenamid, Metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3- Carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline,1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4- [5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate,N,N-Dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine, Methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, Methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, Methyl Methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate, methyl (Z)-2-(5-cyclohexyl methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]-3-methoxy-prop The compound is selected from the group consisting of methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, bixafen, fosetyl-aluminum, TAEGRO®, tea tree oil (extract of the tea tree plant Melaleuca alternifolia (commercially available as Timorex Gold®, a broad spectrum botanical biofungicide)) and methallyl picoxamide, and the weight ratio of component (A) to component (B) is from 15:1 to 1:30. In a preferred embodiment, the composition comprisesThe composition comprises the (S)-enantiomer of compound X.05 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.05 or a salt or N-oxide thereof.

[0048] In another preferred composition according to the invention, component (A) is compound number X.06, 2-[(2,6-difluoro-4-pyridyl)-(2-isopropoxypropanoyl)amino]-N-[2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentriflucoside, Nazole, fenpropizin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflucipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, Tricyclazole, Pyroquilon, Cyflufenamid, Metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3- Carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline,1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4- [5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate,N,N-Dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine, Methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, Methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, Methyl Methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate, methyl (Z)-2-(5-cyclohexyl methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]-3-methoxy-prop The compound is selected from the group consisting of methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, bixafen, fosetyl-aluminum, TAEGRO®, tea tree oil (extract of the tea tree plant Melaleuca alternifolia (commercially available as Timorex Gold®, a broad spectrum botanical biofungicide)) and methallyl picoxamide, and the weight ratio of component (A) to component (B) is from 15:1 to 1:30. In a preferred embodiment, the composition comprisesThe composition comprises the (S)-enantiomer of compound X.06 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.06 or a salt or N-oxide thereof.

[0049] In another preferred composition according to the invention, component (A) is compound number X.07, 2-[(2-tert-butoxyacetyl)-(2,6-difluoro-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrifluconazole, zole, fenpropizin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflucipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, thoraxol Lycyclazole, Pyroquilon, Cyflufenamid, Metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3- Carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline,1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4- [5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate,N,N-Dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine, Methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, Methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, Methyl Methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate, methyl (Z)-2-(5-cyclohexyl methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]-3-methoxy-prop The compound is selected from the group consisting of methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, bixafen, fosetyl-aluminum, TAEGRO®, tea tree oil (extract of the tea tree plant Melaleuca alternifolia (commercially available as Timorex Gold®, a broad spectrum botanical biofungicide)) and methallyl picoxamide, and the weight ratio of component (A) to component (B) is from 15:1 to 1:30. In a preferred embodiment, the composition comprisesThe composition comprises the (S)-enantiomer of compound X.07 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.07 or a salt or N-oxide thereof.

[0050] In another preferred composition according to the invention, component (A) is compound number X.08, 2-[(2,6-difluoro-4-pyridyl)-(2-isopropoxyacetyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrifluconazole, zole, fenpropizin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflucipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, thoraxol Lycyclazole, Pyroquilon, Cyflufenamid, Metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3- Carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline,1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4- [5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate,N,N-Dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine, Methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, Methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, Methyl Methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate, methyl (Z)-2-(5-cyclohexyl methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]-3-methoxy-prop The compound is selected from the group consisting of methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, bixafen, fosetyl-aluminum, TAEGRO®, tea tree oil (extract of the tea tree plant Melaleuca alternifolia (commercially available as Timorex Gold®, a broad spectrum botanical biofungicide)) and methallyl picoxamide, and the weight ratio of component (A) to component (B) is from 15:1 to 1:30. In a preferred embodiment, the composition comprisesThe composition comprises the (S)-enantiomer of compound X.08 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.08 or a salt or N-oxide thereof.

[0051] In another preferred composition according to the invention, component (A) is compound number X.09, 2-[(2,6-difluoro-4-pyridyl)-(2-methoxypropanoyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrifluconazo. , fenpropizin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflucipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, triflurane, Cyclazole, Pyroquilon, Cyflufenamid, Metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3- Carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline,1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4- [5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate,N,N-Dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine, Methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, Methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, Methyl Methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate, methyl (Z)-2-(5-cyclohexyl methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoate The compound is selected from the group consisting of methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, bixafen, fosetyl aluminum, TAEGRO®, tea tree oil (extract of the tea tree plant Melaleuca alternifolia (commercially available as Timorex Gold®, a broad spectrum botanical biofungicide)) and methallyl picoxamide, and the weight ratio of component (A) to component (B) is from 15:1 to 1:30. In a preferred embodiment, the composition isThe composition comprises the (S)-enantiomer of compound X.09 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.09 or a salt or N-oxide thereof.

[0052] In another preferred composition according to the invention, component (A) is compound number X.10, 2-[(2,6-difluoro-4-pyridyl)-(2-methylsulfonylpropanoyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentriflurane, cyclohexanediamine ... Conazole, fenpropizin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflucipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, Tricyclazole, Pyroquilon, Cyflufenamid, Metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3 -carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline,1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4- [5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate,N,N-Dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine, Methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, Methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, Methyl Methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate, methyl (Z)-2-(5-cyclohexyl methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoate The compound is selected from the group consisting of methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, bixafen, fosetyl aluminum, TAEGRO®, tea tree oil (extract of the tea tree plant Melaleuca alternifolia (commercially available as Timorex Gold®, a broad spectrum botanical biofungicide)) and methallyl picoxamide, and the weight ratio of component (A) to component (B) is from 15:1 to 1:30. In a preferred embodiment, the composition isThe composition comprises the (S)-enantiomer of compound X.10 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.10 or a salt or N-oxide thereof.

[0053] In another preferred composition according to the invention, component (A) is compound number X.11, 2-[(2,6-difluoro-4-pyridyl)-(tetrahydropyran-4-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrif Leuconazole, fenpropizin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflucipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin , tricyclazole, pyroquilon, cyflufenamid, metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3 -carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline,1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4- [5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate,N,N-Dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine, Methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, Methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, Methyl Methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate, methyl (Z)-2-(5-cyclohexyl methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoate The compound is selected from the group consisting of methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, bixafen, fosetyl aluminum, TAEGRO®, tea tree oil (extract of the tea tree plant Melaleuca alternifolia (commercially available as Timorex Gold®, a broad spectrum botanical biofungicide)) and methallyl picoxamide, and the weight ratio of component (A) to component (B) is from 15:1 to 1:30. In a preferred embodiment, the composition isIt comprises the (S)-enantiomer of compound X.11 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.11 or a salt or N-oxide thereof.

[0054] In a more preferred composition according to the invention, component (A) is compound number X.01, 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-N-(tetrahydrofuran-3-carbonyl)thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, dipheno Conazole, hexaconazole, propiconazole, prothioconazole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isofluxipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil , Cyprodinil, Metalaxyl-M, Aminopyrifen, Folpet, Ipflufenoquin, Quinofumelin, Tricyclazole, Pyroquilon, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl -isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, and the weight ratio of component (A) to component (B) is 15:1 to 1:30. In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.01 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.01 or a salt or N-oxide thereof.

[0055] In another preferred composition according to the invention, component (A) is compound number X.02, 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-2-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, Propiconazole, Prothioconazole, Mefentrifluconazole, Fenpropidin, Fenpropimorph, Fluxapyroxad, Fluopyram, Isopyrazam, Sedaxane, Benzobindiflupyr, Pydiflumetofen, Isoflucipram, Isofetamide, Pyrapropoin, Fluindapyr, Fenpicoxamide, Florylpicoxamide, Chlorothalonil, Mancozeb, Mandipropamide, Oxathiapiproline, Fluazinam, Fludioxonil, Cyprodinil, Metha Laxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline X.02, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, and the weight ratio of component (A) to component (B) is 15:1 to 1:30. In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.02 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.02 or a salt or N-oxide thereof.

[0056] In another preferred composition according to the invention, component (A) is compound number X.03, 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, Propiconazole, Prothioconazole, Mefentrifluconazole, Fenpropidin, Fenpropimorph, Fluxapyroxad, Fluopyram, Isopyrazam, Sedaxane, Benzobindiflupyr, Pydiflumetofen, Isoflucipram, Isofetamide, Pyrapropoin, Fluindapyr, Fenpicoxamide, Florylpicoxamide, Chlorothalonil, Mancozeb, Mandipropamide, Oxathiapiproline, Fluazinam, Fludioxonil, Cyprodinil, Metha Laxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline X.03, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, and the weight ratio of component (A) to component (B) is 15:1 to 1:30. In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.03 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.03 or a salt or N-oxide thereof.

[0057] In another preferred composition according to the invention, component (A) is compound number X.04, 2-[(2,6-difluoro-4-pyridyl)-(oxetane-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propionazole, tetrahydrofuran ... Conazole, prothioconazole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflutipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxil Sil-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinol A compound selected from the group consisting of 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is 15:1 to 1:30. In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.04 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.04 or a salt or N-oxide thereof.

[0058] In another preferred composition according to the invention, component (A) is compound number X.05, 2-[2-tert-butoxypropanoyl-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, proline. Piconazole, prothioconazole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflutamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, methara Xyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline The compound is selected from the group consisting of phosphorus, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, and the weight ratio of component (A) to component (B) is 15:1 to 1:30. In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.05 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.05 or a salt or N-oxide thereof.

[0059] In another preferred composition according to the invention, component (A) is compound number X.06, 2-[(2,6-difluoro-4-pyridyl)-(2-isopropoxypropanoyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, proline. Piconazole, prothioconazole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflutamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, methara Xyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline The compound is selected from the group consisting of phosphorus, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, and the weight ratio of component (A) to component (B) is 15:1 to 1:30. In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.06 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.06 or a salt or N-oxide thereof.

[0060] In another preferred composition according to the invention, component (A) is compound number X.07, 2-[(2-tert-butoxyacetyl)-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, proline. Piconazole, prothioconazole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflutamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, methara Xyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline The compound is selected from the group consisting of X.07, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, and the weight ratio of component (A) to component (B) is 15:1 to 1:30. In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.07 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.07 or a salt or N-oxide thereof.

[0061] In another preferred composition according to the invention, component (A) is compound number X.08, 2-[(2,6-difluoro-4-pyridyl)-(2-isopropoxyacetyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propionazole, tetrahydrofuran ... Conazole, prothioconazole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflutipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxil Sil-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinol X.08, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, and the weight ratio of component (A) to component (B) is 15:1 to 1:30. In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.08 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.08 or a salt or N-oxide thereof.

[0062] In another preferred composition according to the invention, component (A) is compound number X.09, 2-[(2,6-difluoro-4-pyridyl)-(2-methoxypropanoyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propionazole, tetrahydrofuran ... nazole, prothioconazole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isofluxipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxanthrax Le-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinol A compound selected from the group consisting of 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is 15:1 to 1:30. In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.09 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.09 or a salt or N-oxide thereof.

[0063] In another preferred composition according to the invention, component (A) is compound number X.10, 2-[(2,6-difluoro-4-pyridyl)-(2-methylsulfonylpropanoyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, proline. Lopiconazole, Prothioconazole, Mefentrifluconazole, Fenpropidin, Fenpropimorph, Fluxapyroxad, Fluopyram, Isopyrazam, Sedaxane, Benzobindiflupyr, Pydiflumetofen, Isoflucipram, Isofetamide, Pyrapropoin, Fluindapyr, Fenpicoxamide, Florylpicoxamide, Chlorothalonil, Mancozeb, Mandipropamide, Oxathiapiproline, Fluazinam, Fludioxonil, Cyprodinil, Methala Xyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline X.10, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, and the weight ratio of component (A) to component (B) is 15:1 to 1:30. In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.10 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.10 or a salt or N-oxide thereof.

[0064] In another preferred composition according to the invention, component (A) is compound number X.11, 2-[(2,6-difluoro-4-pyridyl)-(tetrahydropyran-4-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, Propiconazole, Prothioconazole, Mefentrifluconazole, Fenpropidin, Fenpropimorph, Fluxapyroxad, Fluopyram, Isopyrazam, Sedaxane, Benzobindiflupyr, Pydiflumetofen, Isoflucipram, Isofetamide, Pyrapropoin, Fluindapyr, Fenpicoxamide, Florylpicoxamide, Chlorothalonil, Mancozeb, Mandipropamide, Oxathiapiproline, Fluazinam, Fludioxonil, Cyprodinil, Metha Laxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline X.11, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, and the weight ratio of component (A) to component (B) is 15:1 to 1:30. In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.11 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.11 or a salt or N-oxide thereof.

[0065] In a preferred composition according to the invention, component (A) is compound number X.01, 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-N-(tetrahydrofuran-3-carbonyl)thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothiophene, tetrahydrofuran-4-carboxylate ... Conazole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflucipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin , Quinofumelin, Tricyclazole, Pyroquilon, Cyflufenamid, Metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline- 3-Carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-Dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-( 1-Methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl ]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[ 5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]prop-2-enoate methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate; methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate; methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)- 3-Methoxy-prop-2-enoate, methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]- A compound selected from the group consisting of 3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, bixafen, fosetylaluminum, TAEGRO®, Timorex Gold® and methallylpicoxamide, wherein the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or even more preferably 5:1 to 1:5). In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.01 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.01 or a salt or N-oxide thereof.

[0066] In another preferred composition according to the invention, component (A) is compound number X.02, 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-2-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrifluconazole, ... Fenpropizin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isofulcipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, Cyflufenamid, Metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-Trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)- 3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclo Propanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]prop-2-enoate methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate; methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate; methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)- 3-Methoxy-prop-2-enoate, methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]- A compound selected from the group consisting of 3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, bixafen, fosetylaluminum, TAEGRO®, Timorex Gold® and methallylpicoxamide, wherein the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or even more preferably 5:1 to 1:5). In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.02 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.02 or a salt or N-oxide thereof.

[0067] In another preferred composition according to the invention, component (A) is compound number X.03, 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrifluconazole, fluconazole, fluoxetine ... Fenpropizin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isofulcipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, Cyflufenamid, Metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-Trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)- 3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclo Propanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]prop-2-enoate methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate; methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate; methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)- 3-Methoxy-prop-2-enoate, methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]- A compound selected from the group consisting of 3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, bixafen, fosetylaluminum, TAEGRO®, Timorex Gold® and methallylpicoxamide, wherein the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or even more preferably 5:1 to 1:5). In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.03 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.03 or a salt or N-oxide thereof.

[0068] In another preferred composition according to the invention, component (A) is compound number X.04, 2-[(2,6-difluoro-4-pyridyl)-(oxetane-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrifluconazole, fenfluconazole, lopidine, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isofulcipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, sif Ruphenamide, Metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro -1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-Trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)- 3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclo Propanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]prop-2-enoate methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate; methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate; methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)- 3-Methoxy-prop-2-enoate, methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]- A compound selected from the group consisting of 3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, bixafen, fosetylaluminum, TAEGRO®, Timorex Gold® and methallylpicoxamide, wherein the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or even more preferably 5:1 to 1:5). In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.04 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.04 or a salt or N-oxide thereof.

[0069] In another preferred composition according to the invention, component (A) is compound number X.05, 2-[2-tert-butoxypropanoyl-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrifluconazole, fentrifluconazole, phenanthrene ... Propizin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isofulcipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, cy Flufenamide, Metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro -1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-Trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)- 3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclo Propanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]prop-2-enoate methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate; methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate; methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)- 3-Methoxy-prop-2-enoate, methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]- A compound selected from the group consisting of 3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, bixafen, fosetylaluminum, TAEGRO®, Timorex Gold® and methallylpicoxamide, wherein the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or even more preferably 5:1 to 1:5). In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.05 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.05 or a salt or N-oxide thereof.

[0070] In another preferred composition according to the invention, component (A) is compound number X.06, 2-[(2,6-difluoro-4-pyridyl)-(2-isopropoxypropanoyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrifluconazole, fentrifluconazole, phenanthrene ... Propizin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isofulcipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, cy Flufenamide, Metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro -1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-Trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)- 3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclo Propanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]prop-2-enoate methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate; methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate; methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)- 3-Methoxy-prop-2-enoate, methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]- A compound selected from the group consisting of 3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, bixafen, fosetylaluminum, TAEGRO®, Timorex Gold® and methallylpicoxamide, wherein the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or even more preferably 5:1 to 1:5). In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.06 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.06 or a salt or N-oxide thereof.

[0071] In another preferred composition according to the invention, component (A) is compound number X.07, 2-[(2-tert-butoxyacetyl)-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrifluconazole, fentrifluconazole, phenanthrene ... Propizin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isofulcipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, cy Flufenamide, Metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro -1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-Trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)- 3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclo Propanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]prop-2-enoate methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate; methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate; methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)- 3-Methoxy-prop-2-enoate, methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]- A compound selected from the group consisting of 3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, bixafen, fosetylaluminum, TAEGRO®, Timorex Gold® and methallylpicoxamide, wherein the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or even more preferably 5:1 to 1:5). In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.07 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.07 or a salt or N-oxide thereof.

[0072] In another preferred composition according to the invention, component (A) is compound number X.08, 2-[(2,6-difluoro-4-pyridyl)-(2-isopropoxyacetyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrifluconazole, fenfluconazole, lopidine, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isofulcipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, sif Ruphenamide, Metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro -1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-Trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)- 3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclo Propanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]prop-2-enoate methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate; methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate; methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)- 3-Methoxy-prop-2-enoate, methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]- A compound selected from the group consisting of 3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, bixafen, fosetylaluminum, TAEGRO®, Timorex Gold® and methallylpicoxamide, wherein the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or even more preferably 5:1 to 1:5). In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.08 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.08 or a salt or N-oxide thereof.

[0073] In another preferred composition according to the invention, component (A) is compound number X.09, 2-[(2,6-difluoro-4-pyridyl)-(2-methoxypropanoyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrifluconazole, fenpro Pyzin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isofulcipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, sif Ruphenamide, Metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro -1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-Trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)- 3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclo Propanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]prop-2-enoate methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate; methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate; methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)- 3-Methoxy-prop-2-enoate, methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]- A compound selected from the group consisting of 3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, bixafen, fosetylaluminum, TAEGRO®, Timorex Gold® and methallylpicoxamide, wherein the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or even more preferably 5:1 to 1:5). In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.09 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.09 or a salt or N-oxide thereof.

[0074] In another preferred composition according to the invention, component (A) is compound number X.10, 2-[(2,6-difluoro-4-pyridyl)-(2-methylsulfonylpropanoyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrifluconazole, phenanthridine, phenylalanine ... ampropizin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isofulcipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, Cyflufenamid, Metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-Trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)- 3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclo Propanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]prop-2-enoate methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate; methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate; methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)- 3-Methoxy-prop-2-enoate, methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]- 3-Methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, bixafen, fosetylaluminum, TAEGRO®, Timorex Gold® and methallylpicoxamide, wherein the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or even more preferably 5:1 to 1:5). In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.10 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.10 or a salt or N-oxide thereof.

[0075] In another preferred composition according to the invention, component (A) is compound number X.11, 2-[(2,6-difluoro-4-pyridyl)-(tetrahydropyran-4-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrifluconazole, ... Fenpropizin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isofulcipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, Cyflufenamid, Metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-Trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)- 3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclo Propanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]prop-2-enoate methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate; methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate; methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)- 3-Methoxy-prop-2-enoate, methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]- 3-Methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, bixafen, fosetylaluminum, TAEGRO®, Timorex Gold® and methallylpicoxamide, wherein the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or even more preferably 5:1 to 1:5). In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.11 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.11 or a salt or N-oxide thereof.

[0076] In another preferred composition according to the invention, component (A) is compound number X.02, 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-2-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propionazonazole, fluoxetine, prothioconazole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflutipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrim Rifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or even more preferably 5:1 to 1:5). In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.02 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.02 or a salt or N-oxide thereof.

[0077] In another preferred composition according to the invention, component (A) is compound number X.03, 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propionazonazole, fluoxetine, prothioconazole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflutipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrim Rifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or even more preferably 5:1 to 1:5). In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.03 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.03 or a salt or N-oxide thereof.

[0078] In another preferred composition according to the invention, component (A) is compound number X.04, 2-[(2,6-difluoro-4-pyridyl)-(oxetane-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, Prothioconazole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflucipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyridine phenanthrene, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3- A compound selected from the group consisting of dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or even more preferably, 5:1 to 1:5). In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.04 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.04 or a salt or N-oxide thereof.

[0079] In another preferred composition according to the invention, component (A) is compound number X.05, 2-[2-tert-butoxypropanoyl-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propidazole, cyclohexacon ... fluoxetine, prothioconazole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isofluximidine, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyri Fen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3 -dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or even more preferably 5:1 to 1:5). In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.05 or a salt or N-oxide thereof.Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.05 or a salt or N-oxide thereof. In another preferred composition according to the invention, component (A) is compound number X.07, 2-[(2-tert-butoxyacetyl)-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifluoroacetamide, or a salt, enantiomer, tautomer or N-oxide thereof. Xystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflutipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, Fludioxonil, Cyprodinil, Metalaxyl-M, Aminopyrifen, Folpet, Ipflufenoquin, Quinofumelin, Tricyclazole, Pyroquilon, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinol X.07, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or even more preferably 5:1 to 1:5). In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.07 or a salt or N-oxide thereof.Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.07, or a salt or N-oxide thereof.

[0080] In another preferred composition according to the invention, component (A) is compound number X.09, 2-[(2,6-difluoro-4-pyridyl)-(2-methoxypropanoyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, Prothioconazole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflucipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyridine phenanthrene, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3- A compound selected from the group consisting of dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or even more preferably, 5:1 to 1:5). In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.09 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.09 or a salt or N-oxide thereof.

[0081] In another preferred composition according to the invention, component (A) is compound number X.11, 2-[(2,6-difluoro-4-pyridyl)-(tetrahydropyran-4-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propionazonazole, fluoxetine, prothioconazole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflutipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrim Rifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3 -dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or even more preferably 5:1 to 1:5). In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.11 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.11 or a salt or N-oxide thereof.

[0082] In a preferred composition according to the invention, component (A) is compound number X.02, 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-2-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, azole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflucipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipfluf Enoxine, quinofumerine, tricyclazole, pyroquilon, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5- a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-Trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, TAEGRO®, Timorex Gold®, Acibenzolar-S-methyl, Cyflufenamid, Metrafenone, Fosetylaluminum, Methallylpicoxamide, Methyl (Z)-3-Methoxy-2-[2-Methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, Methyl (Z)-3-Methoxy-2-[2-Methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, Methyl (Z)-2-(5-Cyclohexyl-2-methyl-phenoxy)-3-Methoxy cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl) Triazol-2-yl]phenoxy]prop-2-enoate, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] Propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea and ethyl 1-[[4-[5-(trifluoromethyl)-1,2,and 4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, wherein the weight ratio of component (A) to component (B) is 15:1 to 1:30, preferably the weight ratio of component (A) to component (B) is 10:1 to 1:10, or even more preferably 5:1 to 1:5. In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.02 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.02 or a salt or N-oxide thereof.

[0083] In a preferred composition according to the invention, component (A) is compound number X.03, 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, azole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflucipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipfluf Enoxine, quinofumerine, tricyclazole, pyroquilon, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5- a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-Trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, TAEGRO®, Timorex Gold®, Acibenzolar-S-methyl, Cyflufenamid, Metrafenone, Fosetylaluminum, Methallylpicoxamide, Methyl (Z)-3-Methoxy-2-[2-Methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, Methyl (Z)-3-Methoxy-2-[2-Methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, Methyl (Z)-2-(5-Cyclohexyl-2-methyl-phenoxy)-3-Methoxy cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl) Triazol-2-yl]phenoxy]prop-2-enoate, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] Propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea and ethyl 1-[[4-[5-(trifluoromethyl)-1,2,and 4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, wherein the weight ratio of component (A) to component (B) is 15:1 to 1:30, preferably the weight ratio of component (A) to component (B) is 10:1 to 1:10, or even more preferably 5:1 to 1:5. In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.03 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.03 or a salt or N-oxide thereof.

[0084] In another preferred composition according to the invention, component (A) is compound number X.04, 2-[(2,6-difluoro-4-pyridyl)-(oxetane-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, fluoxetine, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflucipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrofen, folpet, ipflufe Noxin, Quinofumerin, Tricyclazole, Pyroquilon, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5- a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-Trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, TAEGRO®, Timorex Gold®, Acibenzolar-S-methyl, Cyflufenamid, Metrafenone, Fosetylaluminum, Methallylpicoxamide, Methyl (Z)-3-Methoxy-2-[2-Methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, Methyl (Z)-3-Methoxy-2-[2-Methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, Methyl (Z)-2-(5-Cyclohexyl-2-methyl-phenoxy)-3-Methoxy cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl) Triazol-2-yl]phenoxy]prop-2-enoate, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] Propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea and ethyl 1-[[4-[5-(trifluoromethyl)-1,2,and 4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30, preferably the weight ratio of component (A) to component (B) is from 10:1 to 1:10, or even more preferably from 5:1 to 1:5. In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.04 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.04 or a salt or N-oxide thereof.

[0085] In a further preferred composition according to the invention, component (A) is compound number X.11, 2-[(2,6-difluoro-4-pyridyl)-(tetrahydropyran-4-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothiazole, tetrahydropyran-4-carbonylamino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof. Oconazole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflucipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipf Rufenoquin, quinofumelin, tricyclazole, pyroquilon, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5 -a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-Trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, TAEGRO®, Timorex Gold®, Acibenzolar-S-methyl, Cyflufenamid, Metrafenone, Fosetylaluminum, Methallylpicoxamide, Methyl (Z)-3-Methoxy-2-[2-Methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, Methyl (Z)-3-Methoxy-2-[2-Methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, Methyl (Z)-2-(5-Cyclohexyl-2-methyl-phenoxy)-3-Methoxy cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl) Triazol-2-yl]phenoxy]prop-2-enoate, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] Propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea and ethyl 1-[[4-[5-(trifluoromethyl)-1,2,and 4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylates, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30, preferably the weight ratio of component (A) to component (B) is from 10:1 to 1:10, or even more preferably from 5:1 to 1:5. In a preferred embodiment, the composition comprises the (S)-enantiomer of compound X.11 or a salt or N-oxide thereof. Alternatively, in a preferred embodiment, the composition comprises the (R)-enantiomer of compound X.11 or a salt or N-oxide thereof.

[0086] The term "fungicide" as used herein means a compound that controls, modifies or prevents the growth of fungi. The term "fungicidally effective amount" means an amount of such a compound or combination of such compounds that is capable of producing an effect on the growth of fungi. A controlling or modifier effect includes any deviation from natural development such as killing, retardation, etc., and prevention includes the formation of a barrier or other defense in the plant to prevent infection by fungi.

[0087] The term "plant" refers to all physical parts of a plant, including seeds, seedlings, seedlings, roots, tubers, stems, stalks, foliage and fruits.

[0088] The term "plant propagation material" means all reproductive parts of a plant, for example seeds or growing parts of a plant, such as cuttings or tubers, including not only seeds in the strict sense, but also roots, fruits, tubers, bulbs, rhizomes and plant parts.

[0089] As used herein, the term "habitat" refers to the field in which plants are growing or in which the seeds of cultivated plants are sown or in which the seeds will be planted in the soil, including the soil, seeds and seedlings, as well as established vegetation.

[0090] The term "TIMOREX Gold™" or "Timorex Gold®" as used herein refers to Tea Tree Oil, which is an extract of the tea tree plant Melaleuca alternifolia, commercially available as Timorex Gold®, a broad-spectrum botanical biofungicide.

[0091] The term TAEGRO™ or TAEGRO® as used herein refers to Bacillus amyloliquefaciens strain FZB24 having accession number DSM 10271, commercially available as TAEGRO®, at 130 g / kg (minimum 1×10 13 This refers to a microbial-based fungicide formulated as a wettable powder containing 13% w / w of cfu / kg.

[0092] The term "g ai / ha" as used herein refers to the application rate given as grams [g] of active ingredient [ai] per unit surface [ha]. The unit hectare (symbol ha) is a square measuring 100 m on each side (1 hm 2 ) or 10,000 square metres. The hectare is a commonly used unit of area in the metric system.

[0093] As used herein, the term "control" refers to reducing the number of pests, eradicating pests and / or preventing further damage by pests, thereby reducing damage to plants or plant-derived products.

[0094] As used herein, the term "pests" refers to insects and mollusks found in agriculture, horticulture, forestry, storage of plant-derived products (such as fruit, grains, and timber); and pests associated with damage to man-made structures. The term pests encompasses all stages of the life cycle of a pest.

[0095] As used herein, the term "effective amount" refers to that amount of a compound or salt thereof that provides a desired effect upon single or multiple application.

[0096] Effective amounts are readily determined by those skilled in the art by the use of known techniques and by observing results obtained under analogous circumstances. Determining an effective amount takes into account a number of factors, including, but not limited to, the type of plant or derived product to which it is applied; the pest and its life cycle to be controlled; the particular compound to be applied; the type of application; and other relevant circumstances.

[0097] As used herein, the term "room temperature" or "RT" or "rt" refers to a temperature of about 15° C. to about 35° C. For example, rt can refer to a temperature of about 20° C. to about 30° C.

[0098] Throughout this specification, the expression "composition" refers to various mixtures or combinations of components (A) and (B) (including the embodiments defined above), such as single "premixed" forms, multiple spray mixtures such as "tank mixes" made up of individual combinations of single active ingredient components, and combinations of single active ingredients when applied sequentially (i.e., one after the other within a reasonably short time period, such as hours or days). The order in which components (A) and (B) are applied is not critical to the working of the invention.

[0099] The compositions of the present invention are effective against harmful microorganisms, such as those causing phytopathogenic diseases, in particular against phytopathogenic fungi and bacteria.

[0100] The compositions of the present invention can be used to control plant diseases caused by a broad spectrum of fungal plant pathogens in the classes Basidiomycete, Ascomycete, Oomycete and / or Deuteromycete, Blasocladiomycete, Chrytidiomycete, Glomeromycete and / or Mucoromycete.

[0101] The compositions are effective in controlling a broad spectrum of plant diseases, including foliar pathogens of ornamental crops, turf, vegetables, field crops, cereals and fruit crops.

[0102] These pathogens may include: The class Oomycete includes: Phytophthora diseases such as those caused by Phytophthora capsici, Phytophthora infestans, Phytophthora sojae, Phytophthora fragariae, Phytophthora nicotianae, Phytophthora cinnamomi, Phytophthora citricola, Phytophthora citrophthora and Phytophthora erythroseptica; Pythium aphanidermatum, Pythium aerenomanes, Pythium Pythium diseases such as those caused by P. arrhenomanes, Pythium graminicola, Pythium irregulare and Pythium ultimum; diseases caused by Peronospora destructor, Peronospora parasitica, Plasmopara viticola, Plasmopara halstedii, Pseudoperonospora cubensis, Albugo candida, Sclerophthora macrospora and Bremia lactucae;and others such as Aphanomyces cochlioides, Labyrinthula zosterae, Peronosclerospora sorghi and Sclerospora graminicola; Ascomycetes, such as Stemphylium solani, Stagonospora tainanensis, Spirocaea oleaginea, Setosphaeria turcica, Pyrenochaeta lycoperisici, Pleospora herbarum, Phoma destructiva, Phaeosphaeria herpotrichoides, Phaeocryptocus gaeumannii, Ophiosphaerella graminicola, Ophiobolus graminis, graminis, Leptosphaeria maculans, Hendersonia creberrima, Helminthosporium triticirepentis, Setosphaeria turcica, Drechslera glycines, Didymella bryoniae, Cycloconium oleagineum, Corynespora cassiicola, Cochliobolus sativus, Bipolaris cactivora, Venturia inaequalis, Pyrenophora teres), Pyrenophora tritici-repentis, Alternaria alternata, Alternaria brassicicolaPleosporales, such as Alternaria brassicicola, Alternaria solani, and Alternaria tomatophila; Capnodiales, such as Septoria tritici, Septoria nodorum, Septoria glycines, Cercospora arachidicola, Cercospora sojina, Cercospora zeae-maydis, Cercosporella capsellae, and Cercosporella herpotrichoides; Cladosporium carpophyllum, carpophilum, Cladosporium effusum, Passalora fulva, Cladosporium oxysporum, Dothistroma septosporum, Isariopsis clavispora, Mycosphaerella fijiensis, Mycosphaerella graminicola, Mycovellosiella koepkeii, Phaeoisariopsis bataticola, Pseudocercospora vitis, Pseudocercosporella herpotrichoides herpotrichoides, Ramularia beticola, Ramularia collo-cygni, Gaeumannomyces graminisMagnaporthales such as Magnaporthe grisea, Pyricularia oryzae, Anisogramma anomala, Apiognomonia errabunda, Cytospora platani, Diaporthe phaseolorum, Discula destructiva, Gnomonia fructicola, Greeneria uvicola, Melanconium juglandinum, Phomopsis viticola, Sirococcus clavigignenti-Juglandacearum, clavigignenti-juglandacearum, Tubakia dryina, Dicarpella spp., Valsa ceratosperma, and other Diaporthales; as well as Actinothyrium graminis, Ascochyta pisi, Aspergillus flavus, Aspergillus fumigatus, Aspergillus nidulans, Asperisporium caricae, Blumeriella jaapii, Candida spp., Capnodium ramosum, Cephaloascus spp., Cephalosporium gramineum, Ceratocystis paradoxaparadoxa, Chaetomium spp., Hymenoscyphus pseudoalbidus, Coccidioides spp., Cylindrosporium padi, Diplocarpon malae, Drepanopeziza campestris, Elsinoe ampelina, Epicoccum nigrum, Epidermophyton spp., Eutypa lata, Geotrichum candidum, Gibellina spp. blotch, spot, blast or blight and / or rot diseases such as those caused by others such as Gloeocercospora sorghi, Gloeodes pomigena, Gloeosporium perennans; Gloeotinia temulenta, Griphospaeria corticola, Kabatiella lini, Leptographium microsporum, Leptosphaerulinia crassiasca, Lophodermium seditiosum, Marssonina graminicola, graminicola, Microdochium nivale, Monilinia fructicola, Monographella albescens, Monosporascus cannonballus, Naemacyclusspp., Ophiostomanovo-ulmi, Paracoccidioides brasiliensis, Penicillium expansum, Pestalotia rhododendri, Petriellidium spp., Pezicula spp., Phialophora gregata, Phyllachora pomigena, Phymatotrichum omnivora, Physalospora abdita, Plectosporium tabacinum tabacinum, Polyscytalum pustulans, Pseudopeziza medicaginis, Pyrenopeziza brassicae, Ramulispora sorghi, Rhabdocline pseudotsugae, Rhynchosporium secalis, Sacrocladium oryzae, Scedosporium spp., Schizothyrium pomi, Sclerotinia sclerotiorum, Sclerotinia minor; Sclerotium spp), Typhula ishikariensis, Seimatosporium mariae, Lepteutypa cupressi, Septocyta ruborum, Sphaceloma perseae, Sporonema phacidioides, Stigmina palmivora, Tapesia yallundae, Taphrina bullata, Thielviopsis basicola, Trichoseptoria fructigena, Zygophiala jamaicensis; e.g. Blumeria graminis, Erysiphe polygoni, Uncinula necator, Sphaerotheca fuligena, Podosphaera powdery mildew diseases, such as those caused by Erysiphales, such as Podospaera macularis, Golovinomyces cichoracearum, Leveillula taurica, Microsphaera diffusa, Oidiopsis gossypii, Phyllactinia guttata and Oidium arachidis;For example, Dothiorella aromatica, Diplodia seriata, Guignardia bidwellii, Botrytis cinerea, Botryotinia allii, Botryotinia fabae, Fusicoccum amygdali, Lasiodiplodia theobromae, Macrophoma theicola, Macrophomina phaseolina, Phyllosticta fungi, such as those caused by the Botryosphaeriales, for example Colletotrichum gloeosporioides, Colletotrichum lagenarium, Colletotrichum gossypii, Glomerella cingulata and Colletotrichum graminicola; anthracnose, for example those caused by the Glommerelales, for example Colletotrichum gloeosporioides, Colletotrichum lagenarium, Colletotrichum gossypii, Glomerella cingulata and Colletotrichum graminicola;and for example, Acremonium strictum, Claviceps purpurea, Fusarium culmorum, Fusarium graminearum, Fusarium virguliforme, Fusarium oxysporum, Fusarium subglutinans, Fusarium oxysporum f.sp.cubense, Gerlachia nivale, Gibberella fujikuroi, Gibberella zeae, Gliocladium spp., Myrothecium Wilt or blight diseases such as those caused by Hypocreales such as Trichoderma verrucaria, Nectria ramulariae, Trichoderma viride, Trichothecium roseum and Verticillium theobromae; Basidiomycete including smut fungi such as those caused by the Ustilaginales, e.g. Ustilaginoidea virens, Ustilago nuda, Ustilago tritici, Ustilago zeae, e.g. Cerotelium fici, Chrysomyxa arctostaphyli, Coleosporium ipomoeae, Hemileia vastatrix, Puccinia arachidis, Puccinia cacabata, Puccinia graminis ... graminis, Puccinia recondita, Puccinia sorghi, Puccinia hordei, Puccinia striiformis f.sp.Hordei, Puccinia striiformis f.sp.rust fungi, such as those caused by the orders Pucciniales, such as Cronartium ribicola, Gymnosporangium juniperi-viginianae, Melampsora medusae, Phakopsora pachyrhizi, Phragmidium mucronatum, Physopella ampelosidis, Tranzschelia discolor and Uromyces viciae-fabae; and Cryptococcus spp. spp.), Exobasidium vexans, Marasmiellus inoderma, Mycena spp., Sphacelotheca reiliana, Typhula ishikariensis, Urocystis agropyri, Itersonilia perplexans, Corticium invisum, Laetisaria fuciformis, Waitea circinata, Rhizoctonia solani, Thanetephorus cucurmeris, Entyloma Other decays and diseases such as those caused by Bacillus dahliae, Entylomella microspora, Neovossia moliniae and Tilletia caries. Blastocladiomycetes, such as Physoderma maydis. Mucoromycetes, such as Choanephora cucurbitarum, Mucor spp., and Rhizopus arrhizus. and diseases caused by other species and genera closely related to those listed above.

[0103] In addition to its fungicidal activity, the composition may also have activity against bacteria such as Erwinia amylovora, Erwinia caratovora, Xanthomonas campestris, Pseudomonas syringae, Strptomyces scabies and other related species, as well as certain protozoa.

[0104] The compositions of the present invention may be used in the class Ascomycetes (e.g., Venturia, Podosphaera, Erysiphe, Monilinia, Mycosphaerella, Uncinula); Basidiomycetes (e.g., Hemileia, Rhizoctonia, Phakopsora, Puccinia, Ustilago, Tilletia); Fungi imperfecti (e.g., Fungi spp ... imperfecti (synonym: Deuteromycetes; e.g. Botrytis, Helminthosporium, Rhynchosporium, Fusarium, Septoria, Cercospora, Alternaria, Pyricularia and Pseudocercosporella) osporella); Oomycetes (e.g. Phytophthora, Peronospora, Pseudoperonospora, Albugo, Bremia, Pythium, Pseudosclerospora, Plasmopara).

[0105] Useful plant crops in which the compositions of the present invention can be used are typically berry plants, such as blackberries, blueberries, cranberries, raspberries, and strawberries; cereals, such as barley, corn (corn), millet, oats, rice, rye, sorghum, triticale, and wheat; fiber plants, such as cotton, flax, hemp, jute, and sisal; field crops, such as sugar and fodder beets, coffee, hops, mustard, oilseed rape (canola), poppy, sugarcane, sunflower, tea, and tobacco; fruit trees, such as apples, apricots, avocados, bananas, cherries, citrus fruits, nectarines, peaches, pears, and plums; and grasses, such as bermudagrass, berry bush, bentgrass, centipedegrass, fescue, ryegrass, lawn grass, and lawn grass. herbs, such as basil, borage, chives, coriander, lavender, lovage, mint, oregano, parsley, rosemary, sage and thyme; legumes, such as beans, lentils, peas and soybeans; nuts, such as almonds, cashews, groundnuts, hazelnuts, peanuts, pecans, pistachios and walnuts; palms, such as oil palm; ornamental plants, such as flowers, shrubs and trees; other trees, such as cocoa, coconut, olive and rubber; vegetables, such as asparagus, eggplant, broccoli, cabbage, carrots, cucumber, garlic, lettuce, squash, melon, okra, onion, pepper, potato, pumpkin, rhubarb, spinach and tomato; and perennial and annual crops, such as vines, such as grapes.

[0106] Crops are understood to be those occurring naturally, obtained by traditional breeding methods or obtained by genetic engineering, including crops that contain so-called output traits (e.g. increased storage stability, higher nutritional value and improved flavor).

[0107] Crops are also understood to include crops that have been made tolerant to herbicides such as bromoxynil or classes of herbicides such as ALS-, EPSPS-, GS-, HPPD- and PPO-inhibitors. An example of a crop that has been made tolerant to imidazolinones, such as imazamox, by traditional breeding methods is Clearfield® summer canola. Examples of crops that have been made tolerant to herbicides by genetic engineering methods include glyphosate- and glufosinate-resistant corn varieties, such as those available under the trade names RoundupReady®, Herculex I® and LibertyLink®.

[0108] Crops should also be understood to be those that are naturally occurring or that have been rendered resistant to harmful insects. This includes plants that have been transformed, for example by using recombinant DNA techniques, to have the ability to synthesize one or more selectively acting toxins, such as those known to be derived from toxin-producing bacteria. Examples of toxins that can be expressed include δ-endotoxins, vegetative insecticidal proteins (Vip), insecticidal proteins of nematode symbiotic bacteria, and toxins produced by scorpions, arachnids, wasps and fungi.

[0109] An example of a crop modified to express Bacillus thuringiensis toxins is Bt corn KnockOut® (Syngenta Seeds). An example of a crop containing two or more genes encoding insecticide resistance and thus expressing two or more toxins is VipCot® (Syngenta Seeds). Crops or their seed material can also be resistant to multiple pests (so-called overlapping transgenic events when formed by genetic modification). For example, plants can be herbicide resistant and at the same time capable of expressing insecticidal proteins, such as Herculex I® (Dow AgroSciences, Pioneer Hi-Bred International).

[0110] The term "useful plants" should also be understood to include useful plants which have been transformed using recombinant DNA techniques so as to be capable of synthesizing one or more selectively acting toxins, such as those known from toxin-producing bacteria, in particular those of the genus Bacillus.

[0111] Examples of such plants are YieldGard® (a corn variety expressing a CryIA(b) toxin); YieldGard Root Feeders® (a corn variety expressing a CryIIIB(b1) toxin); YieldGard Plus® (a corn variety expressing a CryIA(b) and a CryIIIB(b1) toxin); Starlink® (a corn variety expressing a Cry9(c) toxin); Herculex I® (a corn variety expressing a CryIF(a2) toxin and the enzyme phosphinothricin N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B® (a cotton variety expressing a CryIA(c) toxin); Bollgard I® (a cotton variety expressing a CryIA(c) toxin); Bollgard II® (a cotton variety expressing CryIA(c) and CryIIA(b) toxins); VIPCOT® (a cotton variety expressing VIP toxin); NewLeaf® (a potato variety expressing CryIIIA toxin); NatureGard® Agrisure® GT Advantage (GA21 glyphosate tolerance trait), Agrisure® CB Advantage (Bt11 corn borer (CB) trait), Agrisure® RW (corn root-feeding nematode trait) and Protecta®.

[0112] The term "crop plant" should also be understood to include crop plants which have been transformed using recombinant DNA techniques so as to be capable of synthesizing one or more selectively acting toxins, such as those known from toxin-producing bacteria, particularly those of the genus Bacillus.

[0113] Toxins which can be expressed by the transformed plant include, for example, insecticidal proteins from Bacillus cereus or Bacillus popilliae; or insecticidal proteins from Bacillus thuringiensis, such as δ-endotoxins, for example Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), for example Vip1, Vip2, Vip3 or Vip3A; or insecticidal proteins from Photorhabdus spp. or Xenorhabdus spp., for example Photorhabdus luminescens, Xenorhabdus nematophilus, for example spp.); toxins produced by animals such as scorpion toxins, spider toxins, wasp toxins and other insect-specific neurotoxins; toxins produced by fungi such as Streptomycete toxins, plant lectins such as pea lectin, barley lectin or snowdrop lectin; agglutinins; proteinase inhibitors such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin, papain inhibitors; ricin, Ribosome-inactivating proteins (RIPs) such as maize-RIP, abrin, rufin, saporin or bryodin; steroid metabolic enzymes such as 3-hydroxysteroid oxidase, ecdysteroid-UDP-glycosyl-transferase, cholesterol oxidase, ecdysone inhibitors, HMG-COA-reductase, ion channel blockers such as sodium or calcium blockers, juvenile hormone esterase, diuretic hormone receptor, stilbene synthase, bibenzyl synthase, chitinase and glucanase.

[0114] In the context of the present invention, it should be understood that δ-endotoxins, such as Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or trophic insecticidal proteins (Vip), such as Vip1, Vip2, Vip3 or Vip3A, are also in particular hybrid toxins, truncated toxins and modified toxins. Hybrid toxins are recombinantly produced by new combinations of different domains of these proteins (see, for example, WO 02 / 15701). Truncated toxins, such as truncated Cry1Ab, are known. In the case of modified toxins, one or more amino acids of the natural toxin are replaced. In such amino acid substitutions, preferably a non-naturally occurring protease recognition sequence is inserted into the toxin, for example in the case of Cry3A055 a cathepsin-G recognition sequence is inserted into the Cry3A toxin (see WO 03 / 018810).

[0115] Examples of such toxins or transformed plants capable of synthesizing such toxins are disclosed, for example, in EP 0 374 753, WO 93 / 07278, WO 95 / 34656, EP 0 427 529, EP 451 878 and WO 03 / 052073.

[0116] The processes for the preparation of such transformed plants are generally known to those skilled in the art and are described, for example, in the above-mentioned publications. CryI-type deoxyribonucleic acids and their preparation are known, for example, from WO 95 / 34656, EP 0 367 474, EP 0 401 979 and WO 90 / 13651.

[0117] The toxins contained in the transformed plants confer resistance to the plants against harmful insects, which can be from any taxonomic group of insects, but are particularly commonly found in beetles (Coleoptera), two-winged insects (Diptera) and butterflies (Lepidoptera).

[0118] Transgenic plants containing one or more genes encoding insecticide resistance and expressing one or more toxins are known, and some are commercially available. Examples of such plants include YieldGard® (a corn variety expressing Cry1Ab toxin); YieldGard Rootworm® (a corn variety expressing Cry3Bb1 toxin); YieldGard Plus® (a corn variety expressing Cry1Ab and Cry3Bb1 toxins); Starlink® (a corn variety expressing Cry9C toxin); Herculex I® (a corn variety expressing Cry1Fa2 toxin and the enzyme phosphinothricin N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B® (a cotton variety expressing Cry1Ac toxin); Bollgard I® (a cotton variety expressing Cry1Ac toxin); Bollgard II® (a cotton variety expressing Cry1Ac and Cry2Ab toxins); VipCot® (a cotton variety expressing Vip3A and Cry1Ab toxins); NewLeaf® (a potato variety expressing Cry3A toxin); NatureGard®, Agrisure® GT Advantage (GA21 glyphosate-tolerant trait), Agrisure® CB Advantage (Bt11 corn borer (CB) trait), and Protecta®.

[0119] Further examples of such transformed crops are as follows: 1. Bt11 maize, registration number C / FR / 96 / 05 / 10, manufactured by Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31 790 St. Sauveur, France. A genetically engineered maize (Zea mays) that is resistant to the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a truncated Cry1Ab toxin. Bt11 maize also achieves tolerance to the herbicide glufosinate ammonium by transgenic expression of the enzyme PAT.

[0120] 2. Bt176 maize, registration number C / FR / 96 / 05 / 10, manufactured by Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31 790 St. Sauveur, France. A genetically engineered maize (Zea mays) that is resistant to the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of the Cry1Ab toxin. Bt176 maize also achieves tolerance to the herbicide glufosinate ammonium by transgenic expression of the enzyme PAT.

[0121] 3. MIR604 maize, registration number C / FR / 96 / 05 / 10, from Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31 790 St. Sauveur, France. Maize conferred insect resistance by transgenic expression of a modified Cry3A toxin. The toxin is Cry3A055 modified by the insertion of a cathepsin-G-protease recognition sequence. The preparation of such transformed maize plants is described in WO 03 / 018810.

[0122] 4. MON863 maize, registration number C / DE / 02 / 9, from Monsanto Europe SA 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium. MON863 expresses the Cry3Bb1 toxin and confers resistance to certain coleopteran insects.

[0123] 5. IPC531 Cotton made by Monsanto Europe SA 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C / ES / 96 / 02.

[0124] 6. 1507 corn from Pioneer Overseas Corporation, Avenue Tedesco, 7 B-1160 Brussels, Belgium, registration number C / NL / 00 / 10. Maize genetically engineered for expression of the protein Cry1F to achieve resistance to certain lepidopteran insects and for expression of the PAT protein to achieve resistance to the herbicide glufosinate ammonium.

[0125] 7. NK603 x MON810 maize, registration number C / GB / 02 / M3 / 03, from Monsanto Europe SA 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium. It consists of a conventional hybrid maize variety by crossing the genetically engineered varieties NK603 and MON810. NK603 x MON810 maize transgenic expresses the protein CP4 EPSPS from Agrobacterium sp. strain CP4, which confers resistance to the herbicide Roundup® (containing glyphosate), and the Cry1Ab toxin from Bacillus thuringiensis subsp. kurstaki, which confers resistance to certain Lepidoptera, including the European corn borer.

[0126] Also, Absidia corymbifera, Alternaria spp., Aphanomyces spp., Ascochyta spp., Aspergillus spp. including A. flavus, A. fumigatus, A. nidulans, A. niger, A. terrus, Aureobasidium spp. including A. pullulans, Blastomyces dermatitidis, Blumeria graminis, Bremia lactucae, lactucae, B. dothidea, B. obtusa, Botryosphaeria spp. including B. cinerea, C. albicans, C. glabrata, C. krusei, C. lusitaniae, C. parapsilosis, C. tropicalis, Candida spp., Cephaloascus fragrans, Ceratocystis spp. spp., Cercospora spp. including C. arachidicola, Cercosporidium personatum, Cladosporium spp., Claviceps purpurea, Coccidioides immitis, Cochliobolus spp., Colletotrichum spp. including C. musae.), Cryptococcus neoformans, Diaporthe spp., Didymella spp., Drechslera spp., Elsinoe spp., Epidermophyton spp., Erwinia amylovora, Erysiphe spp. including E. cichoracearum, Eutypa Fusarium spp. including F. lata, F. culmorum, F. graminearum, F. langsethiae, F. moniliforme, F. oxysporum, F. proliferatum, F. subglutinans, F. solani, Gaeumannomyces graminis, Gibberella fujikuroi, Gloeodes pomigena, Gloeosporium musarum, Glomerella cinquefolia, Glomerella spp. cingulate, Guignardia bidwellii, Gymnosporangium juniperi-virginianae, Helminthosporium spp., Hemileia spp., Histoplasma spp. including H. capsulatum.), Laetisaria fuciformis, Leptographium lindbergi, Leveillula taurica, Lophodermium seditiosum, Microdochium nivale, Microsporum spp., Monilinia spp., Mucor spp., Mycosphaerella spp. including M. graminicola, M. pomi, Oncobasidium theobromaeon, Ophiostoma pisae, piceae, Paracoccidioides spp., Penicillium spp. including P. digitatum, P. italicum, Petriellidium spp., Peronosclerospora spp. including P. maydis, P. philippinensis and P. sorghi, Peronosclerospora spp., Phaeosphaeria nodorum, Phakopsora pachyrhizi, Phellinus ignialus igniarus, Phialophora spp., Phoma spp., Phytophthora spp. including Phomopsis viticola, P. infestans, Plasmopara spp. including P. halstedii, P. viticola, Pleospora spp.), Podosphaera spp. including P. leucotricha, Polymyxa graminis, Polymyxa betae, Pseudocercosporella herpotrichoides, Pseudomonas spp., Pseudoperonospora spp. including P. cubensis, P. humuli, Pseudopezizatrakeiphila spp. Puccinia spp., including P. tracheiphila, P. hordei, P. recondita, P. striiformis, P. triticina, Pyrenopeziza spp., Pyrenophora spp., Pyricularia spp., including P. oryzae, Pythium spp., including P. ultimum, Ramularia spp., Rhizoctonia spp., Rhizomucor pusillus, Rhizopus arizus, arrhizus, Rhynchosporium spp., Scedosporium spp. including S. apiospermum and S. prolificans, Schizothyrium pomi, Sclerotinia spp., Sclerotium spp., S. nodorum, S. tritici, S.tritici), Sphaerotheca macularis, Sphaerotheca fusca (Sphaerotheca fuliginea), Sporothorix spp., Stagonospora nodorum, Stemphylium spp., Stereum hirsutum, Thanatephorus cucumeris, Thielaviopsis basicola, Tilletia spp. spp., Trichoderma spp. including T. harzianum, T. pseudokoningii, T. viride, Trichophyton spp., Typhula spp., Uncinula necator, Urocystis spp., Ustilago spp., Venturia spp. including V. inaequalis,), Verticillium spp. and Xanthomonas spp., in particular Zymoseptoria tritici, Puccinia recondita, Puccinia striiformis, Erysiphe graminis, Uncinula necator, Sphaerotheca fuliginea, Leveillula taurica, Phakopsora pachyrhizi, Pyricularia oryzae, Alternaria solani, Alternaria alternata, alternata, Mycosphaerella fijiensis, Colletotrichum lagenarium, Didymella bryoniae, Ascochyta pisii, Verticillium dahliae, Pyrenophora teres, Cercospora beticola, Ramularia collo-cygni, Botrytis cinerea,. No cross-resistance has been observed between any fungicidal solution used to control phytopathogenic fungi, such as Sclerotinia sclerotiorum, Monilinia laxa, Monographaella nivalis and Venturia inaequalis, and a composition comprising a mixture of components (A) and (B).

[0127] Indeed, fungicidal resistant strains of any of the above mentioned species have been reported in the scientific literature, where the strains are resistant to one or more fungicides according to at least one of the following fungicidal mode of action classifications: quinone external inhibitors (QoI), quinone internal inhibitors (QiI), succinate dehydrogenase inhibitors (SDHI) and sterol demethylation-inhibitors (DMI). Such fungicidal resistant strains may include: Mutations in the mitochondrial cytochrome b gene that confer resistance to Qo inhibitors, the mutations being G143A, F129L or G137R. See, for example, Gisi et al., Pest Manag Sci 56, 833-841, (2000); Lucas, Pestic Outlook 14(6), 268-70 (2003); Fraaije et al., Phytopathol 95(8), 933-41 (2005); Sierotzki et al., Pest Manag Sci 63(3), 225-233 (2007); Semar et al., Journal of Plant Diseases and Protection(3), 117-119 (2007); and Pasche et al., Crop Protection 27(3-5), 427-435 (2008). Mutations in the mitochondrial cytochrome b gene that confer resistance to Qi inhibitors, where the mutations are G37A / C / D / S / V or N31K. See, for example, Meunier et al., Pest Manag Sci 2019;75:2107-2114; Young et al., Pest Manag Sci 2018;74(2):489-498; Walker et al., Environmental Microbiology,2021(https: / / doi.org / 10.1111 / 1462-2920.15760). Mutations in the genes encoding the SdhB, C, and D subunits that confer resistance to SDHI inhibitors, where the mutations are in the following major pathogens: Botrytis cinerea: B-P225H / L / T / Y / F, B-N230I, B-H272L / Y / R, C-P80H / L, C-N87S; Alternaria solani: B-H278R / Y, C-H134R / Q, D-D123E, D-H133R and C-H134R; Zymoseptoria tritici: in sdhB: N225T, N225I, R265P, T268I, T268A. in sdhC: T79N, T79I, W80S, W80A, A84F, N86S, N86A, P127A, R151M / S / T / G, R151S, R151T, H152R / Y, V166M, T168R. in sdhD: I50F, M114V, D129G, T20P+K186R; Pyrenophora teres: in sdhB: S66P, N235I, H277Y. in sdhC: K49E, R64K, N75S, G79R, H134R, S135R. in sdhD: D124E, H134R, G138V, D145G; Ramularia collo-cygni: in sdhB: N224T, T267I. in sdhC: N87S, G91R, H146R / L, G171D, H153R; Phakopsora pachyrhizi: C-I86F; Sclerotinia sclerotiorum: in sdhB: H273Y. in sdhC: G91R, H146R. in sdhD: T108K, H132R, G150R.

[0128] The main sources of information are www.frac.info, Sierotzki and Scalliet Phytopathology (2013) 103(9):880-887 and Simoes et al., J Plant Dis Prot (2018) 125:21-2. Mutations or combinations of mutations in the CYP51 gene that confer resistance to DMI inhibitors, where the mutations are: L50S, D134G, V136A / C, Y137F, S188N, A379G, I381V, deletions 459-460, Y461H / S, N513K, S524T. Main sources of information are www.frac.info, Cools et al., Plant Pathol(2013)62:36-42 and Schmitz HK et al., Pest Manag Sci(2014)70:378-388.

[0129] Therefore, in a preferred embodiment, the composition according to the invention comprising a mixture of components (A) and (B) is used for controlling fungal strains that are resistant to one or more fungicides according to any of the following fungicidal MoA classifications: quinone external inhibitors (QoI), quinone internal inhibitors (QiI), succinate dehydrogenase inhibitors (SDHI) and sterol demethylation-inhibitors (DMI).

[0130] The compounds of the invention, or salts or N-oxides thereof, can be made as shown in the following Schemes, in which, unless otherwise specified, the definition of each variable is as defined above for compounds of formula (I).

[0131] The compounds of formula (Ia) according to the present invention, 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 is as defined in formula (I), and R 8 is hydrogen) can be prepared by reacting a compound of formula (II) 2 , R 3 , R 4 , R 5 , R 6 and R 7 is as defined in formula (I)) into a compound of formula (III) 1is as defined in formula (I) and Xa is a halogen, preferably bromo or chloro), which can be obtained by conversion either by thermal heating or with a base (Scheme 1)). Scheme 1 [ka]

[0132] One skilled in the art will recognize that the conditions used to prepare a compound of formula (Ia) will depend on the stoichiometry of the reaction. For example, reacting 1-1.5 equivalents of a compound of formula (III) with 1 equivalent of a compound of formula (II) will produce primarily a compound of formula (Ia), whereas reacting 2-2.1 equivalents of a compound of formula (III) with 1 equivalent of a compound of formula (II) will produce a compound of formula (Ib), where R 8a is C 1 ~C 6 Alkoxy C 1 ~C 6 Alkyl carbonyl, C 1 ~C 6 Alkyl Sulfanyl C 1 ~C 6 Alkyl carbonyl, C 1 ~C 6 Alkyl Sulfinyl C 1 ~C 6 Alkyl carbonyl, C 1 ~C 6 Alkyl Sulfonyl C 1 ~C 6 alkylcarbonyl or heterocyclylcarbonyl, where heterocyclyl is a 4-, 5-, or 6-membered non-aromatic monocyclic ring containing 1, 2, or 3 heteroatoms independently selected from nitrogen, oxygen, and sulfur (Scheme 2). Scheme 2 [ka]

[0133] A compound of formula (II) 2 , R 3 , R4 , R 5 , R 6 and R 7 are as defined in formula (I), 2 is as defined in formula (I) into a compound of formula (V), 3 , R 4 , R 5 , R 6 and R 7 is as defined in formula (I) and Xb is a halogen, preferably bromo or chloro), either by thermal heating or by using a base or under transition metal catalyzed Buchwald-Hartwig amination conditions (Scheme 3). Such compounds of formula (II) are described in WO 2019 / 105933. Scheme 3 [ka]

[0134] A compound of formula (V) 3 , R 4 , R 5 , R 6 and R 7 is as defined in formula (I) and Xb is halogen, preferably bromo or chloro, can be prepared by reacting a compound of formula (VI) 2 is as defined in formula (I) and Xb is halogen, preferably bromo, and a compound of formula (VII) 4 , R 5 , R 6 and R 7 is as defined in formula (I)) can be obtained by conversion either via an intermediate acid chloride or directly with a peptide coupling agent (Scheme 4). Scheme 4 [ka]

[0135] A compound of formula (VII) 5 and R 6 are both methyl, and R 4 and R 7 Examples of aryl groups (where both are hydrogen) are: [ka]

[0136] Those skilled in the art will recognize that the compound of formula (VII) may have chiral centers, and individual enantiomers may be prepared by either i) enantioselective conversion of a suitable precursor, ii) resolution of a racemic mixture or a partially enriched mixture by fractional crystallization with enantiomerically enriched acids or metal complexes, or iii) chromatographic separation of the enantiomers using enantiomerically enriched stationary phases. For some representative protocols, see Chiral Amine Synthesis: Methods, Developments and Applications, Wiley, 2010.

[0137] Salts of compounds of formula (VII) can be converted in a manner known per se into other salts, for example acid addition salts, of compounds of formula (VII), for example by treating an inorganic acid salt, such as the hydrochloride, with a suitable metal salt, such as the sodium, barium or silver salt of the acid, for example with silver acetate, in a suitable solvent in which the inorganic salt forming, for example silver chloride, will precipitate from the reaction mixture due to its insolubility.

[0138] Compounds of formula (VII) which have salt-forming properties may be available in the free form or in the form of a salt depending on the procedure or reaction conditions.

[0139] The compounds of formula (VII) and, where appropriate, their tautomers, can exist in the form of one of the possible isomers or as mixtures thereof, either in free form or in salt form, in the form of pure isomers, such as enantiomers and / or diastereomers, or as isomeric mixtures, such as enantiomeric mixtures, such as racemates or diastereomeric mixtures, depending on the number, the absolute and relative configuration of the asymmetric carbon atoms occurring in the molecule and / or the configuration of the non-aromatic double bonds occurring in the molecule, the invention relates to the pure isomers and also to all possible isomeric mixtures, and it shall be understood in this sense in each case above and below, even if in each case no specific reference is made to stereochemical details.

[0140] Depending on which starting materials and procedures have been selected, the diastereomeric or racemic mixtures of compounds of formula (VII) in free or salt form, which may be obtained, can be separated into the pure diastereomers or racemates in known manner based on the physicochemical differences of the components, for example by fractional crystallization, distillation and / or chromatography.

[0141] Enantiomeric mixtures, such as likewise available racemates, can be resolved into their optical antipodes by known methods, for example by recrystallization from optically active solvents, by chromatography on chiral adsorbents, for example by high performance liquid chromatography (HPLC) on acetylcellulose using suitable microorganisms, by cleavage with specific immobilized enzymes via the formation of inclusion compounds, for example using chiral crown ethers, such that only one enantiomer forms a complex, or by conversion into diastereomeric salts, for example by reacting the basic final product racemate with an optically active acid, such as a carboxylic acid, for example camphoric acid, tartaric acid or malic acid, or a sulfonic acid, for example camphorsulfonic acid, and the diastereomeric mixtures thus obtainable can be separated, for example by fractional crystallization on the basis of their different solubilities to give diastereomers, from which the desired enantiomer can be released by the action of a suitable agent, for example a basic agent.

[0142] Pure diastereomers or enantiomers can be obtained according to the invention not only by separation of the appropriate isomeric mixtures but also by generally known diastereoselective or enantioselective synthetic methods, e.g. by carrying out the method according to the invention with starting materials of the appropriate stereochemistry.

[0143] In either case, if the individual components have different biological effectiveness, it may be advantageous to isolate or synthesize the more biologically effective isomer, e.g., enantiomer or diastereomer, or mixture of isomers, e.g., mixture of enantiomers or diastereomers.

[0144] For example, compounds with two or more asymmetric carbon atoms may exist in diastereomeric forms that may be separated, for example, using supercritical fluid chromatography (SFC) chromatography on a chiral column. Although such diastereomers may exhibit different bactericidal efficacy profiles, all isomers and diastereomers form part of the present invention.

[0145] The compound of formula (VII) has three chiral carbon atoms (three stereocenters, here marked with an asterisk ( * ) indicate the chiral carbon atom, so there are eight possible stereoisomers. These eight stereoisomers consist of four pairs of enantiomers. [ka]

[0146] For compounds of formula (VII), the relationship between the enantiomers and diastereomers is illustrated below.

[0147] Those skilled in the art will appreciate that these diastereomers and enantiomers of formula (VII) are 4 , R 5 , R 6 and R 7is well known to be within the scope of the present invention as defined in formula (I). [ka]

[0148] The compounds of formula (VII) and, where appropriate, their tautomers, whether in free form or in salt form, may also be obtained, where appropriate, in the form of hydrates and / or may include other solvents, such as those that may have been used for the crystallization of compounds present in solid form.

[0149] A compound of formula (VI) 3 is as defined in formula (I) and Xb is halogen, preferably bromo or chloro), to give a compound of formula (VIII), 3 is as defined in formula (I), Xb is halogen, preferably bromo or chloro, and R 9 is C 1 ~C 6 This can be obtained by converting a cycloalkyl group (which is an alkyl group) and a base. This is shown in Scheme 5 (below). Scheme 5 [ka]

[0150] Alternatively, a compound of formula (II) 2 and A are as defined in formula (I) can be prepared by reacting a compound of formula (IX) 2 , R 3 and A are as defined in formula (I) to prepare a compound of formula (VII), 4 , R 5 , R 6 and R 7 is as defined in formula (I)) can be obtained by conversion either via an intermediate acid chloride or directly with a peptide coupling agent (Scheme 6). Scheme 6 [ka]

[0151] A compound of formula (IX) 2 , A and R 3 is as defined in formula (I) 2 , R 3 and A are as defined in formula (I), and R 10 is C 1 ~C 6 The aryl aryl groups can be obtained by conversion of the corresponding aryl groups (alkyl) with a base (Scheme 7). Scheme 7 [ka]

[0152] A compound of formula (X) 2 , A and R 3 is as defined in formula (I), and R 10 is C 1 ~C 6 A compound of formula (IV) 2 is as defined in formula (I) into a compound of formula (VII) 3 is as defined in formula (I), Xb is halogen, preferably bromo or chloro, and R 10 is C 1 ~C 6 alkyl) by either thermal heating, or by using base, or under transition metal catalyzed Buchwald-Hartwig amination conditions (Scheme 8). Scheme 8 [ka]

[0153] Alternatively, a compound of formula (X) 2 , A and R 3 is as defined in formula (I), and R10 is C 1 ~C 6 is a compound of formula (XI) 2 and A are as defined in formula (I) and Xc is halogen, preferably bromo or iodo) to a compound of formula (XII), 3 is as defined in formula (I), and R 10 is C 1 ~C 6 can be obtained by conversion to 1,2-diphenylmethane (alkyl) under conditions of a transition metal catalyzed Buchwald-Hartwig amination, as shown in Scheme 9 (below). Scheme 9 [ka]

[0154] Alternatively, a compound of formula (II) 2 , R 3 , R 4 , R 5 , R 6 and R 7 are as defined in formula (I), 2 is as defined in formula (I) and Xc is halogen, preferably bromo or iodo) to a compound of formula (XIII), 3 , R 4 , R 5 , R 6 and R 7 is as defined in formula (I)) which can be obtained by conversion either by thermal heating or by using a base or under transition metal catalyzed Buchwald-Hartwig amination conditions (Scheme 10). Scheme 10 [ka]

[0155] The compositions of the present invention, including all of the embodiments and preferred examples thereof disclosed above, may also be mixed with one or more additional pesticides, such as further fungicides, insecticides, nematicides, bactericides, acaricides, plant growth regulators, sterilizers, semiochemicals, repellents, attractants, pheromones, feeding stimulants or other bioactive compounds to form multi-component pesticides providing even broader spectrum agricultural protection.

[0156] Examples of such agricultural protection agents that can be formulated with the compositions of the present invention are: Etridiazole, Fluazinam, Benalaxyl, Benalaxyl-M (Chiralaxyl), Furalaxyl, Metalaxyl, Metalaxyl-M (Mefenoxam), Dodisin, N'-(2,5-dimethyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidine, N'-[4-(4,5-dichloro-thiazol-2-yloxy)-2,5-dimethyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-[[3-[(4 -Chlorophenyl)methyl]-1,2,4-thiadiazol-5-yl]oxy]-2,5-dimethyl-phenyl]-N-ethyl-N-methyl-formamidine, ethirimol, 3'-chloro-2-methoxy-N-[(3RS)-tetrahydro-2-oxofuran-3-yl]aceto-2',6'-xylidide (clozylacon), cyprodinil, mepanipyrim, pyrimethanil, dithianon, aureofungin, blasticidin-S, biphenyl, chloro Neb, dicloran, benzovindiflupyr, pydiflumetofen, hexachlorobenzene, quintozene, tecnazene (TCNB), tolclofos-methyl, metrafenone, 2,6-dichloro-N-(4-trifluoromethylbenzyl)-benzamide, fluopicolide (flupicolide), tioximide, flusulfamide, benomyl, carbendazim, carbendazim chlorhydrate, chlorphenazole, fuberidazole, thiabendazole, thiazole Ofanate-methyl, benthiavalicarb, clobenziazone, probenazole, acibenzolar, bethoxazin, pyriophenone (IKF-309), acibenzolar-S-methyl, pyribencarb (KIF-7767), butylamine, 3-iodo-2-propynyl n-butylcarbamate (IPBC), picarbutrazox, polycarbamate, propamocarb, tolprocarb, 3-(difluoromethyl)-N-(7-fluoro-1,1,3,3-tetramethyl-indan-4-yl)-1-methyl-pyrazole-4-carboxamide, diclocymet, N-[(5-chloro-2-isopropyl-phenyl)methyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-pyrazole-4-carboxamide, N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-[(2-isopropylphenyl)methyl]-1-methyl-pyrazole-4-carboxamide, carpropamid, chlorothalonil, flumorph, oxine-copper, cymoxanil, fenamacril, cyazofamid, flutianil, thiciophen, chlozolinate, iprodione, procymidone, vinclozolin, bupirimate, dinoktone, dinopentone, dinobutone, dinocap, meptyldinocap, diphenylamine, phosdaifen, 2,6-Dimethyl-[1,4]dithiino[2,3-c:5,6-c']dipyrrole-1,3,5,7(2H,6H)-tetraone, azithiram, etham, ferbam, mancozeb, maneb, metham, metiram (polyram), metiram-zinc, nabam, propineb, thiram, bepam (metam sodium), zineb, ziram, dithioether, isoprothiolane, ethaboxam, fosetyl ), fosetyl-Al (fosetyl-al), methyl bromide, methyl iodide, methyl isothiocyanate, cyclafuramide, fenfuram, validamycin, streptomycin, (2RS)-2-bromo-2-(bromomethyl)glutaronitrile (bromothalonil), dodine, dogudine, guazatine, iminoctadine, iminoctadine triacetate, 2,4-D, 2,4-DB, kasugamycin, dimethirimol, fenhexamid, hymexazole, hydroxyisoxazole, imazalil, imazalil sulfate, oxypoconazole, pefurazoate, prochloraz, triflumizole, fenamidone, Bordeaux mixture, calcium polysulfide, copper acetate, copper carbonate, copper hydroxide, copper naphthenate, copper oleate, copper oxychloride, copper oxyquinolate, copper silicate, copper sulfate, copper thalate, cuprous oxide, sulfur, carbaryl, phthalide (phthalide), dingjunezuo (Jun Si Qi), oxathiapiproline, fluoroimide, mandipropamid, KSF-1002, benzam- e, dimethomorph, fenpropimorph, tridemorph, dodemorph, diethofencarb, fentin acetate, fentin hydroxide, carboxin, oxycarboxin, drazoxolone, famoxadone, m-phenylphenol, p-phenylphenol, tribromophenol (TBP), 2-[2-[(7,8-difluoro-2-methyl-3-quinolyl)oxy]-6-fluoro-phenyl]propan-2-ol, 2-[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolyl)oxy]phenyl]propan-2-ol cyflufenamid, ofurace, oxadixyl, flutolanil, mepronil, isofetamide, fenpiclonil, fludioxonil, pencycuron, edifenphos, iprobenfos, pyrazophos, phosphoric acid, tecloftalam, captafol, captan, ditalimfos, triforine, fenpropidin, pi Perarin, osthol, 1-methylcyclopropene, 4-CPA, chlormequat, clofencet, dichloroprop, dimethipin, endothal, ethephon, flumetralin, forchlorfenuron, gibberellic acid, gibberellin, hymexazol, maleic hydrazide, mepiquat, naphthaleneacetamide, paclobutrazol, prohexadione, prohexadione-calcium, thidiazuron, tribufos (tributyl phosphorotrithioate), trinexapac, uniconazole, α-naphthaleneacetic acid, polyoxyethylene D (polyoxrim), BLAD, chitosan, fenoxanil, folpet, 3-(difluoromethyl)-N-methoxy-1-methyl-N-[1-methyl-2-(2,4,6-trichlorophenyl)ethyl]pyrazole-4-carboxamide, bixafen, fluxapyroxad, furametpyr, isopyrazam, penflufen, penthiopyrad, sedaxane, fenpyrazamine, diclomedine, pyrifenox, boscalid, fluopyram, diflumetrim, fenarimol, 5-fluoro-2-(p-trifluorophenyl)ethyl, (methoxy)pyrimidin-4-amine, ferimzone, dimethaclone (dimethaclone), pyroquilon, proquinazide, ethoxyquin, quinoxyfen, 4,4,5-trifluoro-3,3-dimethyl-1-(3-quinolyl)isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(3-quinolyl)isoquinoline, 5-fluoro-3,3,4,4-tetramethyl-1-(3-quinolyl)isoquinoline, 9-fluoro-2,2-dimethyl-5-(3-quinolyl)-3H-1,4-Benzoxazepine, tebufloquine, oxolinic acid, quinomethionate (oxythioquinox, quinoxymethionate), spiroxamine, (E)-N-methyl-2-[2-(2,5-dimethylphenoxymethyl)phenyl]-2-methoxy-iminoacetamide, azoxystrobin, cumoxystrobin, dimoxystrobin, enestrobulin, enoxastrobin, fenamistrobin, flufenoxystrobin, fluoxastrobin, kresoxim-methyl, mandestrobin, metaminostrobin, metominostrobin, oryzastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxystrobin, triclopyricarb, trifloxystrobin, amisulbrom, dichlofluanid, trifluanid , but-3-ynyl, N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate, dazomet, isotianil, thiazinil, thifluzamide, benziazole (TCMTB), silthiofam, zoxamide, anilazine, tricyclazole, (rac)-cis-1-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-yl)-cycloheptanol (Huanjunzuo), 1-(5-bromo-2-pyridyl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1,2,4-triazol-1-yl)propan-2-ol, 2-(1-tert-butyl)-1-(2-chlorophenyl)-3-(1,2,4-Triazol-1-yl)-propan-2-ol (TCDP), azaconazole, bitertanol (viloxazole), bromuconazole, climbazole, cyproconazole, difenoconazole, dimethoconazole, diniconazole, diniconazole-M, epoxiconazole, etaconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, ipfentrifluconazole, metconazole, myclobutanil, penconazole, propiconazole, prothioconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triazoxide, triticonazole, mefentrifluconazole, 2-[[(1R,5S)-5-[(4-fluorophenyl)methyl]-1-hydroxy- Fungicides such as 2,2-dimethyl-cyclopentyl]methyl]-4H-1,2,4-triazole-3-thione, 2-[[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl]-4H-1,2,4-triazole-3-thione, amethoctrazine (imidium), iprovalicarb, valifenalate, 2-benzyl-4-chlorophenol (chlorophene), allyl alcohol, azafenidin, benzalkonium chloride, chloropicrin, cresol, daracide, dichlorophen (dichlorophene), difenzoquat, dipyrithione, N-(2-p-chlorobenzoylethyl)-hexaminium chloride, NNF-0721, octhilinone, oxasulfuron, propamidine and propionic acid.

[0157] Abamectin, acephate, acetamiprid, amidoflumet (S-1955), avermectin, azadirachtin, azinphos-methyl, bifenthrin, vinphenazate, buprofezin, carbofuran, cartap, chlorantraniliprole (DPX-E2Y45), chlorfenapyr, chlorfluazuron, chlorpyrifos, chlorpyrifos-methyl, chromafenozide, clothianidin, cyflumetofen, cyfluthrin, β-cytidine Fluthrin, cyhalothrin, lambda-cyhalothrin, cypermethrin, cyromazine, deltamethrin, diafenthiuron, diazinon, dieldrin, diflubenzuron, dimefluthrin, dimethoate, dinotefuran, diofenolan, emamectin, endosulfan, esfenvalerate, ethiprole, fenothiocarb, fenoxycarb, fenpropathrin, fenvalerate, fipronil, flonicamid, flubendiamide, fen Lucithrinate, tau-fluvalinate, flufenerim (UR-50701), flufenoxuron, fonofos, halofenozide, hexaflumuron, hydramethylnon, imidacloprid, indoxacarb, isofenphos, lufenuron, malathion, metaflumizone, metaldehyde, methamidophos, methidathion, methomyl, methoprene, methoxychlor, metofluthrin, monocrotophos, methoxyfenozide, nitenpyram, nichia Insecticides such as gin, novaluron, noviflumuron (XDE-007), oxamyl, parathion, parathion-methyl, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, profenofos, profluthrin, pymetrozine, pyrafluprole, pyrethrins, pyridalyl, pyrifluquinazon, pyriprole, pyriproxyfen, rotenone, ryanodine, spinetoram, spinosad, spirodiclofen, spiromesifen (BSN 2060), spirotetramat, sulprofos, tebufenozide, teflubenzuron, terftrin, terbufos, tetrachlorvinphos, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tralomethrin, triazamate, trichlorfon and triflumuron; bactericides such as streptomycin; Acaricides such as amitraz, quinomethionate, chlorobenzilate, cyenopyrafen, cyhexatin, dicofol, dienochlor, etoxazole, fenazaquin, fenbutatin oxide, fenpropathrin, fenpyroximate, hexythiazox, propargite, pyridaben and tebufenpyrad; and Biological agents such as Bacillus thuringiensis, Bacillus thuringiensis delta-endotoxin, baculovirus and entomopathogenic bacteria, viruses and fungi.

[0158] Other examples of "reference" mixture compositions are as follows (the term "TX" stands for a compound selected from compound numbers X.01, X.02, X.03, X.04, X.05, X.06, X.07, X.08, X.09, X.10 and X.11 as defined in Table X above (following the definition of component (A) of the composition of the present invention): Compounds selected from the group of substances consisting of petroleum + TX, 1,1-bis(4-chlorophenyl)-2-ethoxyethanol + TX, 2,4-dichlorophenylbenzenesulfonate + TX, 2-fluoro-N-methyl-N-1-cinnamaldehyde + TX, 4-chlorophenyl phenylsulfone + TX, acetoprole + TX, aldoxicarb + TX, amidithione + TX, amidothioate + TX, amiton + TX, amiton hydrogen oxalate + TX, amitraz + TX, alamite + TX, arsenic trioxide + TX, azobenzene + TX, azotoate + TX, beno Mil+TX, Benoxafos+TX, Benzylbenzoate+TX, Bixafen+TX, Brofenvalerate+TX, Bromocyclen+TX, Bromophos+TX, Bromopropylate+TX, Buprofezin+TX, Butocarboxim+TX, Butoxycarboxim+TX, Butylpyridaben+TX, Calcium polysulfate+TX, Camphechlor+TX, Carbanolate+TX, Carbophenothione+TX, Cymiazole+TX, Tinomethionate+TX, Chlorbeside+TX, Chlordimeform+TX, Chlordimeform hydrochloride+TX, Chlorbexil Lufenetole+TX, Chlorfenson+TX, Chlorofensulfide+TX, Chlorobenzilate+TX, Chloromebuform+TX, Chlormethiuron+TX, Chloropropylate+TX, Chlorthiophos+TX, Cinerin I+TX, Cinerin II+TX, Cinerins+TX, Closantel+TX, Coumaphos+TX, Crotamiton+TX, Crotoxyphos+TX, Kufraeb+TX, Cyanthoate+TX, DCPM+TX, DDT+TX, Demefion+TX, Demefion-O+TX, Demefion-S+TX, Demeton-methyl+TX, Deme Ton-O+TX, Demeton-O-methyl+TX, Demeton-S+TX, Demeton-S-methyl+TX, Demeton-S-methylsulfone+TX, Dichlofluanid+TX, Dichlorvos+TX, Dicrifos+TX, Dienochlor+TX, Dimefox+TX, Zinex+TX, Zinex-diclexin+TX, Dinocap-4+TX, Dinocap-6+TX, Dinocton+TX, Dinopenton+TX, Dinosulfone+TX, Dinotervone+TX, Dioxathion+TX, Diphenylsulfone+TX, Disulfiram+TX, DNOC+TX, Dofenapine+TX,Doramectin + TX, Endothion + TX, Epirinomectin + TX, Ethoate-methyl + TX, Etrimphos + TX, Fenazaflor + TX, Fenbutatin oxide + TX, Fenothiocarb + TX, Fenpyrad + TX, Fenpyroximate + TX, Fenpyrazamine + TX, Fenson + TX, Fentrifanil + TX, Flubenzimine + TX, Flucycloxuron + TX, Fluenethyl + TX, Fluorobenside + TX, FMC1137 + TX, Formetanate + TX, Formetanate hydrochloride + TX, Formoparanate + TX, γ-H CH+TX, Gliodin+TX, Halfenprox+TX, Hexadecylcyclopropanecarboxylate+TX, Isocarbophos+TX, Jasmolin I+TX, Jasmolin II+TX, Jodofenphos+TX, Lindane+TX, Malonoben+TX, Mecarbam+TX, Mefosfolan+TX, Mesulfen+TX, Methacrifos+TX, Methyl bromide+TX, Metolcarb+TX, Mexacarbate+TX, Milbemycin oxime+TX, Mipafox+TX, Monocrotophos+TX, Morphothion+TX, Moxidectin+TX, Naled+TX, 4-Chloro-2-(2-chloro-2-methyl-propyl)-5-[(6-iodo-3-pyridyl)methoxy]pyridazin-3-one + TX, Nifluridide + TX, Nikkomycin + TX, Nitrilacarb + TX, Nitrilacarb 1:1 zinc chloride complex + TX, Omethoate + TX, Oxydeprophos + TX, Oxydisulfoton + TX, pp'-DDT + TX, Parathion + TX, Permethrin + TX, Fenkapton + TX, Phosalone + TX, Phosphorane + TX, Phosphamidon + TX, Polychloroterpenes + TX, Polynactin + TX, Proclonol +TX, Promacyl +TX, Propoxur +TX, Protidathion +TX, Protoate +TX, Pyrethrin I +TX, Pyrethrin II +TX, Pyrethrin +TX, Pyridafenthion +TX, Pirimitate +TX, Quinalphos +TX, Quinthiophos +TX, R-1492 +TX, Phosglycine +TX, Rotenone +TX, Shladan +TX, Cebufos +TX, Selamectin +TX, Sofamido +TX, SSI-121 +TX, Sulfiram +TX, Sulfuramide +TX, Sulfotep +TX, Sulfur +TX, Diflovidazine +TX, τ-Fulvalinate +TX,TEPP+TX, Terbam+TX, Tetradifon+TX, Tetrasul+TX, Thiafenox+TX, Thiocarboxim+TX, Thiofanox+TX, Thiometon+TX, Thioquinox+TX, Thuringiensin+TX, Triamiphos+TX, Triaratene+TX, Triazophos+TX, Triazuron+TX, Trifenophos+TX, Trinactin+TX, Vamidothion+TX, Vaniliprole+TX, Bethoxazin+TX , copper dioctanoate + TX, copper sulfate + TX, sibutrin + TX, dichloren + TX, dichlorophen + TX, endothal + TX, fentin + TX, hydrated lime + TX, nabam + TX, quinoclamine + TX, quinoneamide + TX, simazine + TX, triphenyltin acetate + TX, triphenyltin hydroxide + TX, crufomate + TX, piperazine + TX, thiophanate + TX, chloralose + TX, fenthion + TX, pyridine -4-Amine + TX, Strychnine + TX, 1-Hydroxy-1H-pyridine-2-thione + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide + TX, 8-Hydroxyquinoline sulfate + TX, Bronopol + TX, Copper hydroxide + TX, Cresol + TX, Dipyrithione + TX, Doditin + TX, Fenaminosulf + TX, Formaldehyde + TX, Hydralagafen + TX, Kasugamycin + TX, Kasugamycin hydrochloride hydrate + TX, Nickel bis(dimethyldithiocarbamate) + TX, Nitrapyrin + TX, Octilinone + TX, Oxolinic acid + TX, Oxytetracycline + TX, Hydroxyquinoline potassium sulfate + TX, Probenazole + TX, Streptomycin + TX, Streptomycin sesquisulfate + TX, Tecloftalam + TX, Thiomersal + TX, Adoxophyes orana GV+TX, Agrobacterium radiobacter+TX, Amblyseius spp.+TX, Anagrapha falcifera NPV+TX, Anagrus atomus+TX, Aphelinus abdominalis+TX, Aphidius colemani+TX,Aphidoletes aphidimyza + TX, Autographa californica NPV + TX, Bacillus sphaericus Neide + TX, Beauveria brongniartii + TX, Chrysoperla carnea + TX, Cryptolaemus montrouzieri + TX, Cydia pomonella GV + TX, Dacnusa sibirica + TX, Diglyphus isaea + TX, Encarsia formosa + TX, Eretmocerus eremicus+TX, Heterorhabditis bacteriophora and H. megidis+TX, Hippodamia convergens+TX, Leptomastix dactylopii+TX, Macrolophus caliginosus+TX, Mamestra brassicae NPV+TX, Metaphycus helvolus+TX, Metarhizium anisopliae var. acridum+TX, Metarhizium anisopliae var. anisopliae+TX, Neodiprion sertifer NPV and N. lecontei NPV + TX, Orius spp. + TX, Paecilomyces fumosoroseus + TX, Phytoseiulus persimilis + TX, Steinernema bibionis + TX,Steinernema carpocapsae + TX, Steinernema feltiae + TX, Steinernema glaseri + TX, Steinernema riobrave + TX, Steinernema riobravis + TX, Steinernema scapterisci + TX, Steinernema spp. + TX, Trichogramma spp. + TX, Typhlodromus occidentalis + TX, Verticillium lecanii)+TX, apholate+TX, visadil+TX, busulfan+TX, dimatif+TX, hemel+TX, hempa+TX, metepa+TX, methiotepa+TX, methyl apholate+TX, molzide+TX, penfluron+TX, tepa+TX, thiohempa+TX, thiotepa+TX, tretamine+TX, uredepa+TX, (E)-dec-5-en-1-yl acetate+(E)-dec-5-en-1-ol+TX, (E)-tridec-4-en-1-yl acetate+TX, (E)-6-methylhept-2-en-4-ol+TX, (E,Z)-tetradec-4,10-dien-1-yl acetate+TX, (Z)-dodec-7-en-1-yl acetate+TX, (Z) -Hexadec-11-enal + TX, (Z)-hexadec-11-en-1-yl acetate + TX, (Z)-hexadec-13-en-11-yn-1-yl acetate + TX, (Z)-icos-13-en-10-one + TX, (Z)-tetradec-7-en-1-al + TX, (Z)-tetradec-9-en-1-ol + TX, (Z)-tetradec-9-en-1-yl acetate + TX, (7E,9Z)-dodeca-7,9-dien-1-yl acetate + TX, (9Z,11E)-tetradec-9,11-dien-1-yl acetate + TX, (9Z,12E)-tetradec-9,12-dien-1-yl acetate + TX, 14-methyloctadec-1-ene + TX,4-Methylnonan-5-ol + 4-methylnonan-5-one + TX, α-multistriatin + TX, Brevicomin + TX, Codrellet + TX, Codremon + TX, Querle + TX, Disparlure + TX, Dodec-8-en-1-yl acetate + TX, Dodec-9-en-1-yl acetate + TX, dodec-8 + TX, 10-dien-1-yl acetate + TX, dominicalure + TX, ethyl 4-methyloctanoate + TX, eugenol + TX, frontalin + TX, grandolure + TX, grandolure I + TX, grandolure II + TX, grandolure III + TX, grandolure IV + TX, hexalure + TX, ipsdienol + TX, ipsenol + TX, japonirure + TX, lineatin + TX, litalure + TX , Louplura + TX, Medlura + TX, Megatomoic acid + TX, Methyleugenol + TX, Muscalure + TX, Octadeca-2,13-dien-1-yl acetate + TX, Octadeca-3,13-dien-1-yl acetate + TX, Olphlura + TX, Orictalure + TX, Ostramon + TX, Siglura + TX, Soldigin + TX, Sulcatol + TX, Tetradec-11-en-1-yl acetate + TX, Trimedlura + TX, Trimedlura A + TX, Trimedlura B 1 +TX, Trimedrua B 2+TX, trimedlure C +TX, trunc-call +TX, 2-(octylthio)-ethanol +TX, butapyronoxyl +TX, butoxy(polypropylene glycol) +TX, dibutyl adipate +TX, dibutyl phthalate +TX, dibutyl succinate +TX, diethyl toluamide +TX, dimethylcarbate +TX, dimethyl phthalate +TX, ethyl hexanediol +TX, hexamide +TX, methoquin-butyl +TX, methyl neodecane amide +TX, oxamate +TX, picaridi 1-Dichloro-1-nitroethane + TX, 1,1-Dichloro-2,2-bis(4-ethylphenyl)-ethane + TX, 1,2-Dichloropropane + 1,3-Dichloropropene + TX, 1-Bromo-2-chloroethane + TX, 2,2,2-Trichloro-1-(3,4-dichlorophenyl)acetate + TX, 2,2-Dichlorovinyl 2-ethylsulfinylethylmethylphosphate + TX, 2-(1,3-Dithiolan-2-yl)phenyldimethylcarbamate + TX, 2-(2-butoxyethoxy)ethylthiocyanate nate + TX, 2-(4,5-dimethyl-1,3-dioxolan-2-yl)phenylmethylcarbamate + TX, 2-(4-chloro-3,5-xylyloxy)ethanol + TX, 2-chlorovinyldiethyl phosphate + TX, 2-imidazolidone + TX, 2-isovalerylindan-1,3-dione + TX, 2-methyl(prop-2-ynyl)aminophenylmethylcarbamate + TX, 2-thiocyanatoethyl laurate + TX, 3-bromo-1-chloroprop-1-ene + TX, 3-methyl-1-phenylpyrazole -5-yldimethylcarbamate + TX, 4-methyl(prop-2-ynyl)amino-3,5-xylylmethylcarbamate + TX, 5,5-dimethyl-3-oxocyclohex-1-enyldimethylcarbamate + TX, acetione + TX, acrylonitrile + TX, aldrin + TX, allosamidin + TX, alixycarb + TX, α-ecdysone + TX, aluminum phosphide + TX, aminocarb + TX, anabasine + TX, atidathion + TX, azamethiphos + TX, Bacillus thuringiensis δ endotoxin + TX, barium hexafluorosilicate + TX,Barium polysulfide +TX, Bartholin +TX, Bayer 22 / 190 +TX, Bayer 22408 +TX, β-cyfluthrin +TX, β-cypermethrin +TX, bioethanomethrin +TX, biopermethrin +TX, bis(2-chloroethyl)ether +TX, sodium borate +TX, bromfenvinphos +TX, bromo-DDT +TX, bufencarb +TX, butacarb +TX, butathiophos +TX, butonate +TX, calcium arsenate +TX, calcium cyanide +TX, carbon disulfide +TX, carbon tetrachloride +TX, cartap hydrochloride +TX, sebazine +TX, chlorbicyclen +TX, chlordane +TX, chlordecone +TX, chloroform +TX, chloropicrin +TX, chlorphoxim +TX, chlorprazophos +TX, cis-resmethrin +TX, cismethrin +TX, clositol Phosphorus+TX, Copper acetoarsenite+TX, Copper arsenate+TX, Copper oleate+TX, Cumitoate+TX, Cryolite+TX, CS708+TX, Cyanofenphos+TX, Cyanophos+TX, Cicrethrin+TX, Cithioate+TX, d-Tetramethrin+TX, DAEP+TX, Dazomet+TX, Decarbofuran+TX, Diamidaphos+TX, Dikapton+TX, Dichlorophenthion+TX, Dicresyl+TX , dicyclanil+TX, dieldrin+TX, diethyl 5-methylpyrazol-3-yl phosphate+TX, dilol+TX, dimefluthrin+TX, dimethane+TX, dimethryn+TX, dimethylvinphos+TX, dimethyllan+TX, dinoprop+TX, dinosam+TX, dinoseb+TX, diofenolan+TX, dioxabenzophos+TX, dicyclophos+TX, DSP+TX, ecdysterone+TX, EI 1642+TX, EMPC+TX, EPBP+TX, Ethaphos+TX, Ethiofencarb+TX, Ethyl Formate+TX, Ethylene Dibromide+TX, Dichloroethane+TX, Ethylene Oxide+TX, EXD+TX, Fenchlorphos+TX, Fenetacarb+TX, Fenitrothion+TX, Fenoxacrim+TX, Fenpyritrin+TX, Fensulfothion+TX, Fenthion-Ethyl+TX, Flucofuron+TX, Fosmetilan+TX, Fospirate+TX, Fostietan+TX, Furathiocarb+TX, Frethrin+TX, Guazatine+TX, Guazatine Acetate+TX,Sodium tetrathiocarboxylate + TX, Halfenprox + TX, HCH + TX, HEOD + TX, Heptachlor + TX, Heterofos + TX, HHDN + TX, Hydrogen cyanide + TX, Hikincarb + TX, IPSP + TX, Isazophos + TX, Isobenzan + TX, Isodrin + TX, Isofenphos + TX, Isorane + TX, Isoprothiolane + TX, Isoxathion + TX, Juvenile hormone I + TX, Juvenile hormone II + TX, Juvenile hormone III + TX, Kereban + TX, Kinoprene + TX, Lead arsenate + TX, Leptophos + TX, Lilimphos + T X, ritidathion + TX, m-cumenyl methyl carbamate + TX, magnesium phosphide + TX, magidox + TX, mecarbone + TX, menazone + TX, mercurous chloride + TX, mesulfenphos + TX, metam + TX, metam-potassium + TX, metam-sodium + TX, methanesulfonyl fluoride + TX, methoclotophos + TX, methoprene + TX, methotrin + TX, methoxychlor + TX, methyl isothiocyanate + TX, methyl chloroform + TX, methylene chloride + TX, methoxadiazone + TX, mirex + TX, naphthalophos + TX, Naphthalene + TX, NC-170 + TX, Nicotine + TX, Nicotine sulfate + TX, Nithiazine + TX, Nornicotine + TX, O-5-Dichloro-4-iodophenyl O-ethyl ethyl phosphonothioate + TX, O,O-Diethyl O-4-methyl-2-oxo-2H-chromen-7-yl phosphorothioate + TX, O,O-Diethyl O-6-methyl-2-propylpyrimidin-4-yl phosphorothioate + TX, O,O,O',O'-Tetrapropyl dithiopyrophosphate + TX, Oleic acid + TX, para-Dichlorobenzene + TX, para Thione-methyl+TX, Pentachlorophenol+TX, Pentachlorophenyl laurate+TX, PH60-38+TX, Fenkapton+TX, Phosnichlor+TX, Phosphine+TX, Phoxim-methyl+TX, Pyrimetaphos+TX, Polychlorodicyclopentadiene isomers+TX, Potassium arsenite+TX, Potassium thiocyanate+TX, Precocene I+TX, Precocene II+TX, Precocene III+TX, Pyrimidophos+TX, Profluthrin+TX, Promecarb+TX, Prothiophos+TX, Pyrazophos+TX, Pyresmethrin+TX,Cassia+TX, Quinalphos-methyl+TX, Quinothione+TX, Rafoxanide+TX, Resmethrin+TX, Rotenone+TX, Cadetrin+TX, Riania+TX, Ryanodine+TX, Sabadila+TX, Shradan+TX, Cebufos+TX, SI-0009+TX, Tiapronil+TX, Sodium arsenite+TX, Sodium cyanide+TX, Sodium fluoride+TX, Sodium hexafluorosilicate+TX, Sodium pentachlorophenoxide salt+TX, Sodium selenate+TX, Sodium thiocyanate+TX, Sodium selenate+TX, Lucofurone+TX, Sulfuron-sodium+TX, Sulfuryl fluoride+TX, Sulprofos+TX, Tar oil+TX, Thionazine+TX, TDE+TX, Tebupirimfos+TX, Temephos+TX, Telarethrin+TX, Tetrachloroethane+TX, Cyclofos+TX, Thiocyclam+TX, Thiocyclam hydrogen oxalate+TX, Thionazine+TX, Thiosultap+TX, Thiosultap-sodium+TX, Tralomethrin+TX, Transpermethrin+TX, Triazamate+TX, Trichlormethaphos-3+TX , Trichloronat+TX, Trimethacarb+TX, Tolprocarb+TX, Triclopyricarb+TX, Triplen+TX, Veratridine+TX, Veratrine+TX, XMC+TX, Zetamethrin+TX, Zinc phosphide+TX, Zolaprophos+TX, Meperfluthrin+TX, Tetramethylfluthrin+TX, Bis(tributyltin)oxide+TX, Bromoacetamide+TX, Ferric phosphate+TX, Niclosamide-olamine+TX, Tributyltin oxide+TX, Pyrimorph+TX, Trifenmorph+TX, 1,2-Dibromo mo-3-chloropropane + TX, 1,3-dichloropropene + TX, 3,4-dichlorotetrahydrothiophene 1,1-dioxide + TX, 3-(4-chlorophenyl)-5-methylrhodanine + TX, 5-methyl-6-thioxo-1,3,5-thiadiazinan-3-ylacetic acid + TX, 6-isopentenylaminopurine + TX, aniciflupurine + TX, benclothiaz + TX, cytokinin + TX, DCIP + TX, rufural + TX, isamidophos + TX, kinetin + TX, Myrothecium verrucaria composition + TX, tetrachlorothiophene + TX, xylenol + TX,Zeatin + TX, Potassium Ethylxanthate + TX, Acibenzolar + TX, Acibenzolar-S-Methyl + TX, Reynoutria sachalinensis Extract + TX, α-Chlorohydrin + TX, Anz + TX, Barium Carbonate + TX, Bisthiosemi + TX, Brodifacoum + TX, Bromadiolone + TX, Bromethalin + TX, Chlorophacinone + TX, Cholecalciferol + TX, coumachlor + TX, coumafuryl + TX, coumatetralyl + TX, crimidine + TX, difenacoum + TX, difethialone + TX, diphacinone + TX, ergocalciferol + TX, flocoumafen + TX, fluoroacetamide + TX, flupropazine + TX, flupropazine hydrochloride + TX, norbormide + TX, fosacetim + TX, phosphorus + TX, pindone + TX, pyrinuron + TX, sciriloside + TX, sodium -fluoroacetate + TX, thallium sulfate + TX, warfarin + TX, -2-(2-butoxyethoxy)ethyl piperonylate + TX, 5-(1,3-benzodioxol-5-yl)-3-hexylcyclohex-2-enone + TX, farnesol + nerolidol + TX, berubutin + TX, MGK 264+TX, piperonyl butoxide+TX, piprotal+TX, propyl isomer+TX, S421+TX, sesamex+TX, sesasmolin+TX, sulfoxide+TX, anthraquinone+TX, copper naphthenate+TX, copper oxychloride+TX, dicyclopentadiene+TX, thiram+TX, zinc naphthenate+TX, ziram+TX, imanin+TX, ribavirin+TX, chlorinconazide+TX, mercury(II) oxide+TX, thiophanate-methyl+TX, azaconazole+TX, bitertanol+TX, bromuconazole+TX, cyproconazole+TX, difenoconazole+TX, diniconazole-+TX, epoxiconazole+TX, fenbuconazole+TX, fluquinconazole+TX, flusilazole+TX , Flutriafol + TX, Furametpyr + TX, Hexaconazole + TX, Imazalil - + TX, Imibenconazole + TX, Ipconazole + TX, Metconazole + TX, Myclobutanil + TX, Paclobutrazol + TX, Pefurazoate + TX, Penconazole + TX, Prothioconazole + TX, Pyrifenox + TX, Prochloraz + TX, Propiconazole + TX, Pyrisoxazole + TX, -Simeconazole + TX, Tebuconazole + TX, Tetraconazole + TX, Triadimefon + TX, Triadimenol + TX, Triflumizole + TX, Triticonazole + TX, Ancymidol + TX, Fenarimol + TX, Nuarimol + TX, Bupirimate + TX, Dimethirimol + TX, Ethyrimol + TX,Dodemorph+TX, Fenpropizin+TX, Fenpropimorph+TX, Spiroxamine+TX, Tridemorph+TX, Cyprodinil+TX, Mepanipyrim+TX, Pyrimethanil+TX, Fenpiclonil+TX, Fludioxonil+TX, Benalaxyl+TX, Furalaxyl+TX, -Metalaxyl-+TX, R-Metalaxyl+TX, Ofrace+TX, Oxadixyl+TX, Carbendazim+TX, Debacarb+TX, Fuberidazole-+TX, Thiabendazole+TX, Chlozolinate+TX, Dichlozolin+TX, Mycozolin-+TX, Propylene+TX Rocimidone+TX, Vinclozolin+TX, Boscalid+TX, Carboxin+TX, Fenfuram+TX, Flutolanil+TX, Mepronil+TX, Oxycarboxin+TX, Penthiopyrad+TX, Thifluzamide+TX, Dodine+TX, Iminoctadine+TX, Azoxystrobin+TX, Dimoxystrobin+TX, Enestrobulin+TX, Phenaminestrobin+TX, Flufenoxystrobin+TX, Fluoxastrobin+TX, Kresoxim-methyl+TX, Metominostrobin+TX, Trifloxystrobin+TX, Oryzast Robin+TX, Picoxystrobin+TX, Pyraclostrobin+TX, Pyrametstrobin+TX, Pyraoxystrobin+TX, Ferbam+TX, Mancozeb+TX, Maneb+TX, Metiram+TX, Propineb+TX, Zineb+TX, Captafol+TX, Captan+TX, Fluorimide+TX, Folpet+TX, Tolylfluanid+TX, Bordeaux mixture+TX, Copper oxide+TX, Mancopper+TX, Oxine copper+TX, Nitrothal-isopropyl+TX, Edifenphos+TX, Iprobenfos+TX, Phosdifen+TX, Turcophos -Methyl+TX, Anilazine+TX, Benthiavalicarb+TX, Blasticidin-S+TX, Chloroneb-+TX, Chlorothalonil+TX, Cyflufenamid+TX, Cymoxanil+TX, Cyclobutrifluram+TX, Diclocymet+TX, Diclomedine-+TX, Dicloran+TX, Diethofencarb+TX, Dimethomorph-+TX, Flumorph+TX, Dithianon+TX, Ethaboxam+TX, Etridiazole+TX, Famoxadone+TX, Fenamidon+TX, Fenoxanil+TX, Ferimzone+TX, Fluazinam+TX,Flumethylsulfoli+TX, Fluopicolide+TX, Fluoxythioconazole+TX, Flusulfamide+TX, Fluxapyroxad+TX, -Fenhexamid+TX, Fosetyl-aluminum-+TX, Hymexazole+TX, Iprovalicarb+TX, Cyazofamid+TX, Methasulfocarb+TX, Metrafenone+TX, Pencycuron+TX, Phthalide+TX, Polyoxin+TX, Propamocarb+TX, Pyribencarb+TX, Proquinazid+TX, Pyroquilon+TX, Pyriophenone+TX, Quinoxyfen+TX, Quinoxazole+TX, ntozene+TX, tiadinil+TX, triazoxide+TX, tricyclazole+TX, triforine+TX, validamycin+TX, valifenalate+TX, zoxamide+TX, mandipropamide+TX, fluveneteram+TX, isopyrazam+TX, sedaxane+TX, benzovindiflupyr+TX, pydiflumetofen+TX, 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (3',4',5'-trifluoro-biphenyl-2-yl)-amide+TX, isoflucipram+TX, isotianil+TX, dipimet Titrone + TX, 6-ethyl-5,7-dioxo-pyrrolo[4,5][1,4]dithiino[1,2-c]isothiazole-3-carbonitrile + TX, 2-(difluoromethyl)-N-[3-ethyl-1,1-dimethyl-indan-4-yl]pyridine-3-carboxamide + TX, 4-(2,6-difluorophenyl)-6-methyl-5-phenyl-pyridazine-3-carbonitrile + TX, (R)-3-(difluoromethyl)-1-methyl-N-[1,1,3-trimethylindan-4-yl]pyrazole-4-carboxamide + TX, 4 -(2-bromo-4-fluoro-phenyl)-N-(2-chloro-6-fluoro-phenyl)-2,5-dimethyl-pyrazol-3-amine+TX, 4-(2-bromo-4-fluoro-phenyl)-N-(2-chloro-6-fluoro-phenyl)-1,3-dimethyl-1H-pyrazol-5-amine+TX, fluindapyr+TX, methoxystrobin (jiaxiangjunzhi)+TX, lvbenmixianan+TX, diclobenziazox+TX, mandestrobin+TX,3-(4,4-difluoro-3,4-dihydro-3,3-dimethylisoquinolin-1-yl)quinolone + TX, 2-[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolyl)oxy]phenyl]propan-2-ol + TX, oxathiapiproline + TX, t-butyl N-[6-[[[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate t+TX, pyraziflumid+TX, inpirfluxam+TX, tulorprocarb+TX, mefentrifluconazole+TX, ipfentrifluconazole+TX, 2-(difluoromethyl)-N-[(3R)-3-ethyl-1,1-dimethyl-indan-4-yl]pyridine-3-carboxamide+TX, N'-(2,5-dimethyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidine+TX TX, N'-[4-(4,5-dichlorothiazol-2-yl)oxy-2,5-dimethyl-phenyl]-N-ethyl-N-methyl-formamidine + TX, [2-[3-[2-[1-[2-[3,5-bis(difluoromethyl)pyrazol-1-yl]acetyl]-4-piperidyl]thiazol-4-yl]-4,5-dihydroisoxazol-5-yl]-3-chloro-phenyl]methanesulfonic acid + TX, Pig -3-ynyl N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate + TX, methyl N-[[5-[4-(2,4-dimethylphenyl)triazol-2-yl]-2-methyl-phenyl]methyl]carbamate + TX, 3-chloro-6-methyl-5-phenyl-4-(2,4,6-trifluorophenyl)pyridazine + TX, Pyridaclomethyl + TX, 3-(difluoromethyl)-1-methyl-N-[1,1,3-trimethylindan-4-yl]pyrazole-4-carboxamide + TX, 1-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-methyl-phenyl]-4-methyl-tetrazol-5-one + TX, 1-methyl-4-[3-methyl-2-[[2-methyl-4-(3,4,5-trimethylpyrazol-1-yl)phenoxy]methyl]phenyl]tetrazol-5-one + TX, aminopyrifen + TX, amethoctrazine + T X, amisulbrom + TX, penflufen + TX, (Z,2E)-5-[1-(4-chlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide + TX, florylpicoxamide + TX, fenpicoxamide + TX, methallylpicoxamide + TX, tebufloquine + TX, ipflufenoquine + TX, quinofumelin + TX, isofetamide + TX, N-[2-[2,4-dichloro-phenoxy]phenyl]-3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide + TX, N- [2-[2-chloro-4-(trifluoromethyl)phenoxy]phenyl]-3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide + TX, benzothiostrobin + TX, phenamacryl + TX, 5-amino-1,3,4-thiadiazole-2-thiol zinc salt (2:1) + TX, fluopyram + TX, flufenoxadiazam + TX, flutianil + TX, fluopimomide + TX, pyrapropoin + TX, picarbutrazox + TX, 2-(difluoromethyl)-N-(3-ethyl-1,1-dimethyl-indan-4-yl)pi Lysine-3-carboxamide + TX, 2-(difluoromethyl)-N-((3R)-1,1,3-trimethylindan-4-yl)pyridine-3-carboxamide + TX, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile + TX, methyltetraprole + TX, 2-(difluoromethyl)-N-((3R)-1,1,3-trimethylindan-4-yl)pyridine-3-carboxamide + TX, α-(1,1-Dimethylethyl)-α-[4'-(trifluoromethoxy)[1,1'-biphenyl]-4-yl]-5-pyrimidinemethanol + TX, fluoxapiproline + TX, enoxastrobin + TX, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile + TX, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-sulfanyl-1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile + TX, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-thioxo-4H-1,2,4-Triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile + TX, trinexapac + TX, cumoxystrobin + TX, zhongshengmycin + TX, copper thiodiazole + TX, zinc thiazole + TX, amethotractin + TX, iprodione + TX, seboctylamin + TX; N'-[5-bromo-2-methyl-6-[(1S)-1-methyl-2-propoxy] N'-[5-bromo-2-methyl-6-[(1R)-1-methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX, N'-[5-chloro-2-methyl-6-[(1R)-1-methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine + TX (these compounds can be prepared according to the method described in WO 2015 / 155075); N'-[5-bromo-2-methyl -6-(2-propoxypropoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX (this compound can be prepared from the method described in IPCOM000249876D); N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine + TX, N'-[4-(1-cyclopropyl-2,2,2-trifluoro-1-hydroxy-ethyl)-5-methoxy-2-methyl-phenyl]-N-isopropyl-N-methyl-formamidine + TX (these compounds can be prepared according to the method described in WO 2018 / 228896); N-ethyl-N'-[5-methoxy-2-methyl-4-[(2-trifluoromethyl)oxetan-2-yl]phenyl]-N-methyl-formamidine + TX, N-ethyl-N'-[5-methoxy-2-methyl-4-[(2-trifluoromethyl)oxetan-2-yl]phenyl]-N-methyl-formamidine + TX N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide + TX, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline 8-Fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide + TX, 8-Fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide + TX, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1S)-1-benzyl-1,3-Dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide + TX, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide + TX, N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide + TX (these compounds can be prepared according to the method described in WO 2017 / 153380); 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline + TX, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline + TX, 4,4-difluoro-3,3-dimethyl-1-(6-methylpyrazolo[1,5-a]pyridin-3 -yl)isoquinoline + TX, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline + TX, 1-(6-chloro-7-methyl-pyrazolo[1,5-a]pyridin-3-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline + TX (these compounds were prepared according to the method described in WO 2017 / 025510). 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline + TX, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline + TX, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline + TX, 4,4-difluoro-1-(5-fluoro-4-methyl-benzimidazol-1-yl)-3,3-dimethyl-isoquinoline + TX, 3-(4,4-difluoro-3,3-dimethyl-1-isoquinolyl)-7,8-dihydro-6H-cyclopenta[e]benzimidazole + TX (these compounds can be prepared according to the method described in WO 2016 / 156085);N-Methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide + TX, N,2-Dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide + TX, N-Ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl ]phenyl]methyl]propanamide + TX, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea + TX, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea + TX, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea + TX sadiazol-3-yl]phenyl]methyl]urea + TX, N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide + TX, 4,4-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one + TX, 5,5-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2 ,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one + TX, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate + TX, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine + TX. The compounds in this paragraph can be prepared from the methods described in WO 2017 / 055473, WO 2017 / 055469, WO 2017 / 093348 and WO 2017 / 118689;2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol + TX (this compound can be prepared from the method described in WO 2017 / 029179); 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol + TX (this compound can be prepared from the method described in WO 2017 / 029179); 3 -[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxypropyl]imidazole-4-carbonitrile + TX (this compound can be prepared from the method described in WO 2016 / 156290); 3-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluorophenyl)-2-hydroxypropyl]imidazole-4-carbonitrile + TX (this compound can be prepared from the method described in WO 2016 / 156290); (4-phenoxyphen N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzenecarbazole + TX (this compound can be prepared from the method described in WO 2014 / 006945); 2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c']dipyrrole-1,3,5,7(2H,6H)tetrone + TX (this compound can be prepared from the method described in WO 2011 / 138281); N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzenecarbazole + TX (this compound can be prepared from the method described in WO 2011 / 138281); rubothioamide + TX; N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide + TX; (Z,2E)-5-[1-(2,4-dichlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide + TX (this compound can be prepared from the method described in WO 2018 / 153707); N'-(2-chloro-5-methyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidine + TX;N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine + TX (this compound can be prepared from the method described in WO 2016 / 202742); 2-(difluoromethyl)-N-[(3S)-3-ethyl-1,1-dimethyl-indan-4-yl]pyridine-3-carboxamide + TX (this compound can be prepared from the method described in WO 2014 / 095675); (5-methyl-2-pyridyl)-[4-[5-(trifluoro (3-methylisoxazol-5-yl)-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methanone + TX, (3-methylisoxazol-5-yl)-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methanone + TX (these compounds can be prepared from the method described in WO 2017 / 220485); 2-oxo-N-propyl-2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide + TX (this compound can be prepared from the method described in WO 2017 / 220485); ethyl 1-[[5-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2-thienyl]methyl]pyrazole-4-carboxylate + TX (this compound can be prepared from the method described in WO 2018 / 158365); 2,2-difluoro-N-methyl-2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide + TX, N-[(E)-methoxyiminomycin N-[(Z)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide + TX, N-[N-methoxy-C-methyl-carbonimidoyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide + TX (these compounds can be prepared from the method described in WO 2018 / 202428).

[0159] The "reference" mixture composition of a mixture of a compound of formula (I) (selected from Table X (above)) with an active ingredient as defined above preferably comprises a compound selected from Table X (above) with an active ingredient as defined above in a mixture ratio of 100:1 to 1:100, in particular 50:1 to 1:50, in particular 20:1 to 1:20, in particular 10:1 to 1:10, in particular 5:1 to 1:5, with a ratio of 2:1 to 1:2 being particularly preferred, and a ratio of 4:1 to 2:1 being likewise preferred, in particular 1:1, or 5:1, or 5:2, or 5:3, or 5:4, or 4:1, or 4: Ratios of 2, or 4:3, or 3:1, or 3:2, or 2:1, or 1:5, or 2:5, or 3:5, or 4:5, or 1:4, or 2:4, or 3:4, or 1:3, or 2:3, or 1:2, or 1:600, or 1:300, or 1:150, or 1:35, or 2:35, or 4:35, or 1:75, or 2:75, or 4:75, or 1:6000, or 1:3000, or 1:1500, or 1:350, or 2:350, or 4:350, or 1:750, or 2:750, or 4:750 are preferred. These mixing ratios are by weight.

[0160] The mixture compositions described above (both the inventive and "reference" mixture compositions) can be used in a method for controlling pests, comprising applying a composition containing the mixture described above to pests or their environment.

[0161] Mixtures comprising a compound of formula (I) selected from Table X (above) and one or more active ingredients as described above can be applied, for example, in a single "premixed" form, as multiple spray mixtures such as "tank mixes" composed of individual combinations of single active ingredient components, and as single active ingredients when applied sequentially (i.e., one after the other within a reasonably short time such as hours or days). The order in which the compound of formula (I) selected from Table X (above) and the active ingredients are applied is not critical to the operation of the invention.

[0162] The compositions of the present invention can also be used in crop enhancement, where "crop enhancement" means, in the present invention, improved plant vigor, improved plant quality, improved resistance to stress factors and / or improved input use efficiency.

[0163] In the present invention, "improved plant vigor" means a qualitative or quantitative improvement in a particular trait when compared to the same trait in a control plant grown under the same conditions in the absence of the method of the present invention. Such traits include, but are not limited to, early and / or improved germination, improved emergence, ability to use fewer seeds, increased root growth, more developed root system, increased nodule formation, increased shoot growth, increased tillers, stronger tillers, more productive tillers, increased or improved plant standing, less plant lodging (lodging), increased and / or improved plant height, increased plant weight (fresh or dry), larger leaf blades, greener leaf color, increased pigment content, increased photosynthetic activity, earlier flowering, longer ears, earlier grains, increased seed, fruit or pod size, increased number of pods or ears, increased number of seeds per pod or ear, increased seed mass, enhanced seed filling, fewer basal leaves, delayed senescence, improved plant vigor, increased amino acid levels in storage tissues and / or less required inputs (e.g. less fertilizer, water and / or labor required). Plants with improved vigor may have an increase in any of the aforementioned traits or any combination or two or more of the aforementioned traits.

[0164] In the present invention, "improved plant quality" means a qualitative or quantitative improvement in a particular trait when compared to the same trait in a control plant grown under the same conditions in the absence of the method of the present invention. Such traits include, but are not limited to, improved plant appearance, reduced ethylene (reduced production and / or suppressed susceptibility), improved quality of the harvested product, such as seeds, fruits, leaves, vegetables, etc. (such improved quality may be manifested as improved visual appearance of the harvested product), improved carbohydrate content (e.g., increased sugar and / or starch amounts, improved sugar acid ratios, reduced reducing sugars, increased rate of sugar production), improved protein content, improved oil content and composition, improved nutritional value, reduced anti-nutritional compounds, improved organoleptic properties (e.g., improved taste) and / or improved consumer health benefits (e.g., increased levels of vitamins and antioxidants), improved post-harvest properties (e.g., enhanced shelf life and / or storage stability, easier processability, easier compound extraction), more uniform crop development (e.g., synchronized germination, flowering and / or fruiting of plants) and / or improved seed quality (e.g., for use in the next growing season). Plants with improved quality may have an increase in any of the above traits or in any combination or two or more of the above traits.

[0165] In the present invention, "improved tolerance to stress factors" means that a particular trait is qualitatively or quantitatively improved when compared to the same trait in a control plant grown under the same conditions in the absence of the method of the present invention. Such traits include, but are not limited to, increased tolerance and / or resistance to abiotic stress factors (e.g., any stress that causes a lack of water in the plant, a lack of water uptake capacity, or a reduced supply of water to the plant) that cause suboptimal growth conditions such as drought, cold exposure, high temperature exposure, osmotic stress, UV stress, flooding, increased salinity (e.g., in the soil), increased exposure to minerals, ozone exposure, high light exposure, and / or limited availability of nutrients (e.g., nitrogen and / or phosphorus nutrients). A plant with improved tolerance to stress factors may have an increase in any of the aforementioned traits or any combination or two or more of the aforementioned traits. In the case of drought and nutritional stress, such improved tolerance may be due to, for example, more efficient uptake, use, or retention of water and nutrients.

[0166] In the present invention, "improved input use efficiency" means that a plant can grow more efficiently using a given input level compared to the growth of a control plant grown under the same conditions in the absence of the method of the present invention. Specifically, the inputs include, but are not limited to, fertilizers (such as nitrogen, phosphorus, potassium, micronutrients), light and water. A plant with improved input use efficiency may have improved use of any of the aforementioned inputs or any combination of two or more of the aforementioned inputs.

[0167] Other crop enhancements of the present invention include reduced plant height or reduced tillering, which are beneficial traits in crops or conditions where it is desirable to have less biomass and fewer tillers.

[0168] Any or all of the above crop enhancements may result in improved yields, for example, by improving plant physiology, plant growth and development, and / or plant architecture. In the context of the present invention, "yield" includes, but is not limited to, (i) increased biomass production, grain yield, starch content, oil content, and / or protein content, which may result from (a) an increase in the amount produced by the plant itself, or (b) an improved ability to harvest the plant body, (ii) improved crop composition (e.g., improved sugar acid ratio, improved oil composition, increased nutritional value, reduced anti-nutritional compounds, increased consumer health benefits), and / or (iii) increased / promoted ability to harvest the crop, improved crop processability, and / or better storage stability / shelf life. Increased yield of an agricultural plant means that, when a quantitative measurement can be made, the yield of the product of the respective plant is increased by a measurable amount over the yield of the same product of a plant produced under the same conditions but without application of the present invention. According to the present invention it is preferred that yield is increased by at least 0.5%, more preferably at least 1%, even more preferably at least 2%, and even more preferably at least 4%, preferably 5% or more.

[0169] Any or all of the above crop intensification may result in improved utilization of land, i.e. land that was previously unavailable or suboptimal for cultivation may become available, for example plants that exhibit an increased ability to survive drought conditions may become cultivated in areas with suboptimal rainfall, such as perhaps on the fringes of deserts or even in the desert itself.

[0170] In one aspect of the invention, crop enhancement is achieved in the substantial absence of pressure from pests and / or diseases and / or abiotic stress. According to a further aspect of the invention, the improvement of plant vigor, stress resistance, quality and / or yield is achieved in the substantial absence of pressure from pests and / or diseases. For example, pests and / or diseases may be controlled by an insecticidal treatment applied prior to or simultaneously with the method of the invention. In yet another aspect of the invention, the improvement of plant vigor, stress resistance, quality and / or yield is achieved in the substantial absence of pressure from pests and / or diseases. In a further embodiment, the improvement of plant vigor, quality and / or yield is achieved in the substantial absence of abiotic stress.

[0171] The composition of the invention can be used in the field of protecting stored goods from fungal attack. In the present invention, the term "storage goods" is understood to mean natural substances of plant and / or animal origin and their processed forms, from which long-term protection from the natural life cycle is desired. Stored goods of plant origin, such as plants or parts thereof (such as stems, leaves, tubers, seeds, fruits or grains), can be protected in the freshly harvested state or in processed forms, such as pre-dried, moistened, crushed, ground, pressed or roasted. The definition of stored goods also includes both wood in the form of raw wood (such as building timber, electricity transmission towers and fences) and wood in the form of finished products (such as furniture or wooden products). Stored goods of animal origin are leather, leather products, furs and hairs. The composition of the invention can prevent adverse effects, such as decay, discolouration or the development of mould. Preferably, "storage products" is understood to mean natural substances of plant origin and / or their processed forms, more preferably fruits and their processed forms, such as pome fruits, drupe fruits, soft fruits and citrus fruits and their processed forms. In another preferred embodiment of the invention, "storage products" is understood to mean trees.

[0172] Therefore, a further aspect of the present invention is a method for protecting a stored item which comprises applying to the stored item a composition of the present invention.

[0173] The composition of the present invention can also be used in the field of protecting industrial raw materials from fungal attack.In the present invention, the term "industrial raw materials" includes paper; carpets; buildings; cooling and heating systems; wallboards; ventilation and air conditioning systems, etc.; preferably, "industrial raw materials" is understood to mean wallboards.The composition of the present invention can prevent adverse effects such as rotting, discoloration or mold growth.

[0174] The compositions of the present invention are usually formulated in various ways using formulation auxiliaries such as carriers, solvents and surface active substances.The formulations can be in various physical forms, such as dusts, gels, wettable powders, wettable granules, water-dispersible granules, water-dispersible tablets, effervescent pellets, emulsifiable concentrates, microemulsifiable concentrates, oil-in-water emulsions, oil-flowables, aqueous dispersions, oil-based dispersions, suspoemulsion formulations, capsule suspensions, emulsifiable granules, soluble liquids, water-soluble concentrates (with water or water-miscible organic solvents as carriers), impregnated polymer films or other forms known, such as from the Manual on Development and Use of FAO and WHO Specifications for Pesticides, United Nations, First Edition, Second Revision (2010).Such formulations can be used directly or diluted before use.Dilution can be carried out, for example, with water, liquid fertilizers, micronutrients, biological organisms, oils or solvents.

[0175] The formulations can be prepared, for example, by mixing the active ingredient with formulation auxiliaries to obtain a composition in the form of a finely divided solid, granules, liquid, dispersion or emulsion. The active ingredient can also be formulated with other auxiliaries, such as finely divided solids, mineral oils, oils of vegetable or animal origin, modified oils of vegetable or animal origin, organic solvents, water, surfactants or combinations thereof.

[0176] The active ingredient can also be contained in microcapsules. Microcapsules contain the active ingredient in a porous carrier. This allows the active ingredient to be released in controlled amounts into the environment (e.g., sustained release). Microcapsules usually have a diameter of 0.1 to 500 microns. They contain the active ingredient in an amount of about 25 to 95% by weight of the capsule weight. The active ingredient can be in the form of a large solid, in the form of fine particles in a solid or liquid dispersion, or in the form of a suitable solution. The encapsulating membrane can, for example, comprise natural or synthetic rubber, cellulose, styrene / butadiene + copolymers, polyacrylonitrile, polyacrylate, polyester, polyamide, polyurea, polyurethane or chemically modified polymers and starch xanthate or other polymers known to those skilled in the art. Alternatively, fine microcapsules can be formed in which the active ingredient is contained in the form of finely divided particles in a solid matrix of the base, but the microcapsules themselves are not encapsulated.

[0177] The formulation auxiliaries suitable for the preparation of the formulations of the present invention are known per se. The following can be used as liquid carriers: water, toluene, xylene, petroleum ether, vegetable oils, acetone, methyl ethyl ketone, cyclohexanone, acid anhydrides, acetonitrile, acetophenone, amyl acetate, 2-butanone, butylene carbonate, chlorobenzene, cyclohexane, cyclohexanol, alkyl esters of acetic acid, diacetone alcohol, 1,2-dichloropropane, diethanolamine, p-diethylbenzene, diethylene glycol, diethylene glycol abietate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, N,N-dimethylformamide, dimethyl sulfoxide, 1,4-dioxane, dipropylene glycol, dipropylene glycol methyl ether, dipropylene glycol dibenzoate, diproxitol, alkylpyrrolidone, ethyl acetate, 2-ethylhexanol, ethylene carbonate, 1,1,1-Trichloroethane, 2-heptanone, α-pinene, d-limonene, ethyl lactate, ethylene glycol, ethylene glycol butyl ether, ethylene glycol methyl ether, γ-butyrolactone, glycerol, glycerol acetate, glycerol diacetate, glycerol triacetate, hexadecane, hexylene glycol, isoamyl acetate, isobornyl acetate, isooctane, isophorone, isopropylbenzene, isopropyl myristate, lactic acid, laurylamine, mesityl oxide, methoxypropanol, methyl isoamyl ketone, methyl isobutyl ketone, methyl laurate, methyl octanoate, methyl oleate, methylene chloride, m-xylene, n-hexane, n-octylamine, octadecanoic acid, octylamine acetate, oleic acid carboxylic acid, oleylamine, o-xylene, phenol, polyethylene glycol, propionic acid, propyl lactate, propylene carbonate, propylene glycol, propylene glycol methyl ether, p-xylene, toluene, triethyl phosphate, triethylene glycol, xylene sulfonic acid, paraffin, mineral oil, trichloroethylene, perchloroethylene, ethyl acetate, amyl acetate, butyl acetate, propylene glycol methyl ether, diethylene glycol methyl ether, methanol, ethanol, isopropanol and higher molecular weight alcohols (amyl alcohol, tetrahydrofurfuryl alcohol, hexanol, octanol, etc.), ethylene glycol, propylene glycol, glycerol, N-methyl-2-pyrrolidone, etc.

[0178] Suitable solid carriers are, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, diatomaceous earth, limestone, calcium carbonate, bentonite, calcium montmorillonite, cottonseed hulls, wheat flour, soybean flour, pumice, wood flour, ground walnut shells, lignin and similar materials.

[0179] A large number of surface-active substances can be advantageously used in both solid and liquid formulations, especially in those which may be diluted with a carrier before use. Surface-active substances can be anionic, cationic, nonionic or polymeric and they can be used as emulsifying agents, wetting agents or suspending agents or for other purposes. Typical surface-active materials include, for example, alkyl sulfates, such as diethanolammonium lauryl sulfate; alkylarylsulfonates, such as calcium dodecylbenzenesulfonate; alkylphenol / alkylene oxide adducts, such as nonylphenol ethoxylate; alcohol / alkylene oxide adducts, such as tridecyl alcohol ethoxylate; soaps, such as sodium stearate; alkylnaphthalenesulfonates, such as sodium dibutylnaphthalenesulfonate; dialkyl esters of sulfosuccinates, such as sodium di(2-ethylhexyl)sulfoccinate; sorbitol esters, such as sorbitol oleate; quaternary amines, such as lauryltrimethylammonium chloride, polyethylene glycol esters of fatty acids, such as polyethylene glycol stearate; block copolymers of ethylene oxide and propylene oxide; and salts of mono- and di-alkyl phosphate esters; and further materials, such as those described in, for example, McCutcheon's Detergents and Emulsifiers Annual, MC Publishing Corp., Ridgewood New Jersey (1981).

[0180] Further auxiliaries which may be used in the agrochemical formulations include crystallization inhibitors, viscosity modifiers, suspending agents, dyes, antioxidants, foaming agents, light absorbers, mixing aids, defoamers, complexing agents, neutralizing or pH adjusting substances and buffers, corrosion inhibitors, fragrances, wetting agents, absorption enhancers, micronutrients, plasticizers, glidants, lubricants, dispersants, thickeners, antifreeze agents, fungicides and liquid and solid fertilizers.

[0181] The formulations of the present invention may contain additives including oils of vegetable or animal origin, mineral oils, alkyl esters of such oils or mixtures of such oils and mixtures with oil derivatives. The amount of oil additive in the formulations of the present invention is usually 0.01-10% based on the mixture to be applied. For example, the oil additive can be added to the spray tank at the desired concentration after the spray mixture is prepared. Preferred oil additives include mineral oils or oils of vegetable origin, such as rapeseed oil, olive oil or sunflower oil, emulsified vegetable oils, alkyl esters of oils of vegetable origin, such as methyl derivatives, or oils of animal origin, such as fish oil or beef tallow. Preferred oil additives include C 8 ~C 22 Alkyl esters of fatty acids, especially C 12 ~C 18 These include methyl derivatives of fatty acids, such as the methyl esters of lauric acid, palmitic acid, and oleic acid (methyl laurate, methyl palmitate, and methyl oleate, respectively). Many oil derivatives are described in the Compendium of Herbicide Adjuvants, 10 th Edition, Southern Illinois University, 2010.

[0182] The formulations usually contain 0.1-99% by weight, in particular 0.1-95% by weight, of the compounds of components (A) and (B) and 1-99.9% by weight of formulation auxiliaries, which preferably include 0-25% by weight of surface-active substances. Commercially available products may preferably be formulated as concentrates, but end users will usually use dilute formulations.

[0183] The application rates vary within wide limits and depend on the nature of the soil, the method of application, the crop plant, the pests to be controlled, the prevailing climatic conditions and other factors which depend on the method and time of application and the target crop. As a general guideline, the compounds can be applied at a rate of 1 to 2000 l / ha, in particular 10 to 1000 l / ha.

[0184] Certain mixture compositions containing the compounds of formula (I) described above may show synergistic effects. This occurs whenever the action of the combination of active ingredients is greater than the sum of the activities of the individual ingredients. The expected activity E for a given combination of active ingredients can be calculated according to the so-called Colby formula as follows (COLBY, SR “Calculating synergistic and antagonistic responses of herbicide combination”. Weeds, Vol. 15, pages 20-22; 1967): ppm = milligrams of active ingredient (=ai) per litre of spray mixture X=% effect of active ingredient A) using p ppm of active ingredient Y=% effect of active ingredient B) using q ppm of active ingredient.

[0185] According to Colby, the expected (active) effect of active ingredients A) + B) using p+q ppm of active ingredients is:

number

[0186] If the actual observed effect (O) is greater than the expected effect (E), the effect of the combination is superadditive, i.e. there is a synergistic effect. In mathematical terms, synergy corresponds to a positive value of the difference (OE). In the case of a pure complementary addition of activities (expected activity), said difference (OE) is zero. A negative value of said difference (OE) indicates a loss of activity compared to the expected activity.

[0187] However, apart from the actual synergistic action with respect to fungicidal activity, the compositions of the present invention may also have surprising advantageous properties.Examples of such advantageous properties that may be mentioned are more advantageous degradability; improved toxicological and / or biotoxicological behavior; or improved properties of useful plants (germination, crop yield, more developed root system, increased tillers, increased plant height, larger leaf blades, less basal leaves, stronger tillers, greener leaf color, less fertilizer required, less seed required, more productive tillers, earlier flowering, earlier grain, less plant verse (lodging), increased shoot growth, improved plant vigor and earlier germination, etc.).

[0188] The compositions of the invention can be applied to phytopathogenic microorganisms, to useful plants, their habitats, their propagation material, stored products or industrial substances threatened by microbial attack.

[0189] The compositions of the invention can be applied before or after the useful plants, their propagation material, stocks or industrial raw materials are infected with microorganisms.

[0190] The amount of the composition of the present invention applied will depend on various factors, such as the composition used; the target of treatment (e.g., plants, soil or seedlings); the type of treatment (e.g., spraying, dusting or seed dressing); the purpose of the treatment (e.g., preventive or curative); the type of fungus to be controlled; or the time of application.

[0191] When applied to useful plants, component (A) is typically applied in an amount of 5 to 2000 g ai / ha, in particular 10 to 1000 g ai / ha, for example 50, 75, 100 or 200 g ai / ha, typically accompanied by 1 to 5000 g ai / ha, in particular 2 to 2000 g ai / ha, for example 100, 250, 500, 800, 1000, 1500 g ai / ha of component (B).

[0192] In agricultural practice, the application rates of the compositions of the invention depend on the type of effect desired and typically range from 20 to 4000 g of total composition per hectare.

[0193] When the compositions of the invention are used to treat seeds, an amount of 0.001 to 50 g per kg of seed, preferably 0.01 to 10 g per kg of seed of the compound of component (A) and 0.001 to 50 g per kg of seed, preferably 0.01 to 10 g per kg of seed of the compound of component (B) will generally be sufficient.

[0194] It is noted that where a reference, patent application, or patent is cited within the text of this application, the entire text of said cited text is incorporated herein by reference. EXAMPLES

[0195] Throughout this specification temperatures are given in degrees Celsius (° C.) and "mp" means melting point. LC / MS means liquid chromatography mass spectrometry, with a description of the instruments and methods as follows.

[0196] Method A: Waters ACQUITY UPLC, Waters UPLC HSS T3, 1.8 mm particle size, 30 x 2.1 mm column, 0.85 mL / min, 60 °C, H 2 O / MeOH95:5+0.05% HCOOH(90%) / CH 3 CN+0.05% HCOOH(10%)-1.2 min -CH 3 CN+0.05% HCOOH(100%)-0.30 min, Waters ACQUITY SQD mass spectrometer, ionization method: electrospray (ESI), polarity: positive ion, capillary (kV) 3.00, cone (V) 30.00, extractor (V) 2.00, source temperature (°C) 150, desolvation temperature (°C) 350, cone gas flow (L / Hr) 0, desolvation gas flow (L / Hr) 650).

[0197] Method B: Waters ACQUITY UPLC, Waters UPLC HSS T3, 1.8 mm particle size, 30 x 2.1 mm column, 0.85 mL / min, 60 °C, H 2 O / MeOH95:5+0.05% HCOOH(90%) / CH 3CN+0.05% HCOOH(10%)-2.7 min -CH 3 CN+0.05% HCOOH(100%)-0.30 min, Waters ACQUITY SQD mass spectrometer, ionization method: electrospray (ESI), polarity: positive ion, capillary (kV) 3.00, cone (V) 30.00, extractor (V) 2.00, source temperature (°C) 150, desolvation temperature (°C) 350, cone gas flow (L / Hr) 0, desolvation gas flow (L / Hr) 650).

[0198] Method C: A Waters ACQUITY mass spectrometer (SQD or SQDII single quadrupole mass spectrometer) with attached electrospray source (polarity: positive or negative ion, capillary: 3.0 kV, cone: 30 V, extractor: 3.00 V, source temperature: 150 °C, desolvation temperature: 400 °C, cone gas flow rate: 60 L / hr, desolvation gas flow rate: 700 L / hr, mass range: 140-800 Da) and a Waters ACQUITY UPLC with attached solvent degasser, binary pump, heated column compartment and diode array detector. Column: Waters UPLC HSS T3, 1.8 μm, 30 × 2.1 mm; temperature: 60 °C; DAD wavelength range (nm): 210–400; solvent gradient: A = water / methanol 9:1 + 0.1% formic acid, B = acetonitrile + 0.1% formic acid; gradient: 0–100% B in 2.5 min; flow rate (ml / min) 0.75).

[0199] [Table 2]

[0200] The active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill to give wettable powders which can be diluted with water to make a suspension of the desired concentration.

[0201] [Table 3]

[0202] The active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill to give a powder which can be used directly for seed treatment.

[0203] emulsifiable concentrate Active ingredients [ingredients (A) and (B)] 10% Octylphenol polyethylene glycol ether 3% (4-5 moles of ethylene oxide) Calcium dodecylbenzenesulfonate 3% Castor oil polyglycol ether (35 moles of ethylene oxide) 4% Cyclohexanone 30% Xylene Mixture 50%

[0204] From this concentrate it is possible, by dilution with water, to obtain emulsions of any required dilution which can be used in plant protection.

[0205] [Table 4]

[0206] Ready-to-use dusts are obtained by mixing the active ingredient with the carrier and grinding the mixture in a suitable mill. Such dusts can also be used for dry dressing of seeds.

[0207] Extrusion molding granules Active ingredients [ingredients (A) and (B)] 15% Sodium Lignosulfonate 2% Carboxymethylcellulose 1% Kaolin 82%

[0208] The active ingredient is mixed with the auxiliaries and ground, the mixture is moistened with water, extruded and then dried in a stream of air.

[0209] Coated Granules Active ingredients [ingredients (A) and (B)] 8% Polyethylene glycol (200 mol wt) 3% Kaolin 89%

[0210] In the mixer, the finely ground active ingredient is applied uniformly to the kaolin moistened with polyethylene glycol, thus obtaining non-dusty coated granules.

[0211] Suspension concentrate Active ingredients [ingredients (A) and (B)] 40% Propylene glycol 10% Nonylphenol polyethylene glycol ether (15 moles of ethylene oxide) 6% Sodium Lignosulfonate 10% Carboxymethylcellulose 1% Silicone oil (in the form of a 75% emulsion in water) 1% water 32%

[0212] When the finely divided active ingredient is mixed homogeneously with the auxiliary, a suspension concentrate is obtained which can be diluted with water to obtain a suspension of any desired dilution, which can be used to combat and protect living plants and plant propagation material against microbial damage by spraying, injection or immersion.

[0213] Flowable concentrates for seed treatment Active ingredients [ingredients (A) and (B)] 40% Propylene glycol 5% Copolymer butanol PO / EO 2% Tristyrene phenol 10-20 mole EO content 2% 1,2-Benzisothiazolin-3-one (in the form of a 20% solution in water) 0.5% Monoazo pigment calcium salt 5% Silicone oil (in the form of a 75% emulsion in water) 0.2% Water 45.3%

[0214] Finely ground active ingredient can be thoroughly mixed with adjuvants to obtain a suspension concentrate which can then be diluted with water to obtain a suspension of any desired dilution. Such dilutions can be used to treat and protect living plants and plant propagation material against infestation by microorganisms by spraying, pouring or immersion.

[0215] Sustained-release capsule suspension 28 parts of a combination of active ingredients [components (A) and (B)] are mixed with 2 parts of an aromatic solvent and 7 parts of a toluene diisocyanate / polymethylene-polyphenylisocyanate mixture (8:1). The mixture is emulsified in a mixture of 1.2 parts of polyvinyl alcohol, 0.05 parts of an antifoaming agent, and 51.6 parts of water until the desired particle size is obtained. To this emulsion is added a mixture of 2.8 parts of 1,6-diaminohexane in 5.3 parts of water. The mixture is stirred until the polymerization reaction is complete. The resulting capsule suspension is stabilized by adding 0.25 parts of a thickener and 3 parts of a dispersing agent. The capsule suspension formulation contains 28% active ingredient. The diameter of the medium-sized capsules is 8 to 15 microns. The resulting formulation is applied to the seeds as an aqueous suspension in a device suitable for that purpose.

[0216] List of abbreviations: °C = degrees Celsius, CDCl 3 = chloroform-d, d = doublet, DCM = dichloromethane, DMF = dimethylformamide, HATU = 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate, m = multiplet, MHz = megahertz, N = normal, RT = room temperature, s = singlet

[0217] Preparation Example The synthetic techniques described both above and below may be used to prepare compounds of formula (I) or salts or N-oxides thereof accordingly.

[0218] 1 H NMR and 19 F NMR measurements were recorded on a Bruker 400 MHz spectrometer. Chemical shifts are expressed as TMS(1 H) and CFCl3( 19 F) are presented in ppm relative to standards. Spectra were run in deuterated solvents as indicated. Compounds were characterized using one of the following LCMS methods. Characteristic LCMS values ​​obtained for each compound were retention time ("Rt", reported in minutes) and molecular ion measurement (M+H). + or (MH) - It was.

[0219] Example P1: Preparation of 2-[(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide: [ka] a) Preparation of 2-[(2,6-difluoro-4-pyridyl)amino]-5-methyl-thiazole-4-carbonyl chloride: [ka] To a suspension of 2-[(2,6-difluoro-4-pyridyl)amino]-5-methyl-thiazole-4-carboxylic acid (0.250 g, 0.92 mmol) in DCM (9.2 mL, 0.1 M) at room temperature, DMF (1 drop) and oxalyl chloride (2 eq., 0.235 g, 1.85 mmol, 0.162 mL) were added dropwise (with slight gas evolution upon addition) and the reaction mixture was stirred at room temperature. After 30 min, gas evolution ceased and the reaction mixture became homogeneous. The reaction mixture was concentrated in vacuo to give 2-[(2,6-difluoro-4-pyridyl)amino]-5-methyl-thiazole-4-carbonyl chloride as a yellow gum, which was used in the next step without any further purification. 1 H NMR (400MHz, DMSO-d6): δ ppm 2.68 (s, 3H), 7.60 (s, 2H), 13.70-14.60 (broad line s, 1H).

[0220] 2-[(2,6-difluoro-4-pyridyl)amino]-5-methyl-thiazole-4-carbonyl chloride may also be obtained as a salt, for example the hydrochloride salt.

[0221] b) Preparation of 2-[(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide: [ka] To a cold (0° C.) solution of 2-[(2,6-difluoro-4-pyridyl)amino]-5-methyl-thiazole-4-carbonyl chloride in DCM (3 mL, 0.3 M) was added 2,2-dimethylcyclobutylamine hydrochloride (1.1 eq., 1.02 mmol, 138 mg) and triethylamine (2 eq., 1.85 eq., 187 mg, 0.259 mL) and the mixture was stirred at room temperature for 7 h. The reaction mixture was diluted with water and the two phases were separated. The aqueous phase was extracted with EtOAc and the combined organic phases were dried over anhydrous sodium sulfate, filtered and concentrated. Purification of the residue by flash chromatography afforded 2-[(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide as an off-white solid. 1 H-NMR (400MHz, CDCl 3 ):δppm 1.17(s,3H),1.20(s,3H),1.50-1.75(m,2H),1.86-1.92(m,1H),2.29-2.36(m ,1H),2.79(s,3H),4.25-4.31(m,1H),6.87(s,2H),7.32(d,1H),7.67(s,1H).

[0222] Example P2: Preparation of 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (Example X.03, Table X) and 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-N-(tetrahydrofuran-3-carbonyl)thiazole-4-carboxamide (Example X.01, Table X) [ka] (Compound X.03, Table X), and [ka] (Compound X.01, Table X) A solution of tetrahydrofuran-3-carboxylic acid (0.174 g, 0.143 mL, 1.48 mmol) in DCM (9 mL) under argon was treated with a drop of DMF followed by oxalyl chloride (0.192 g, 0.13 mL, 1.48 mmol). The mixture was stirred at room temperature under argon for 30 minutes to give tetrahydrofuran-3-carbonyl chloride. To this DCM solution was added 2-[(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (0.350 g, 0.993 mmol) followed by triethylamine (0.308 g, 0.42 mL, 2.98 mmol) at room temperature under argon. The resulting pale yellow solution was stirred at room temperature under argon until LCMS analysis showed the reaction was complete after 2.5 hours. The reaction mixture was treated with Isolute® and concentrated in vacuo. Purification by flash chromatography eluting with ethyl acetate / cyclohexane gave a mixture of two products which was further purified by reverse phase chromatography to give the first eluting product, 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (Example X.03, Table X) as a white powder.1 H NMR (400 MHz, CDCl 3 ):δppm 0.94(s,3H)1.13(s,3H)1.49-1.59(m,2H)1.65-1.78(m,1H)1.95-2.15(m,1H)2.19-2.30(m,1H)2.30-2.40(m,1H)2.81(s, 3H)2.99-3.14(m,1H)3.80-3.88(m,1H)3.88-3.95(m,1H)3.95-4.06(m,2H)4.10-4.26(Quadruple line,1H)6.89(s,2H)6.95-7.06(Wide line d,1H); LC-MS (Method A): 451 [M+H], Rt: 1.09 min.

[0223] Further elution gave a second crop, 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-N-(tetrahydrofuran-3-carbonyl)thiazole-4-carboxamide (compound X.01, Table 2) as a white powder. 1 H NMR (400 MHz, CDCl 3 ):δppm 1.09(s,3H)1.18(s,3H)1.53-1.66(m,2H)1.77-1.91(m,1H)2.07-2.22(m,2H)2.23-2.34(m,1H)2.41-2.51+2.62-2.71 (2×m,2H)2.81(s,3H)3.10-3.26(m,1H)3.77-4.05(m,6H)4.14-4.31+4.37-4.43(2×m,3H)6.81-6.92(2×s,2H)7.20(br d,J=8.44Hz,1H); LC-MS (Method A): 549[M+H], Rt: 1.15 min.

[0224] Example P3: Preparation of 2-[(2,6-difluoro-4-pyridyl)-(oxetane-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (Example X.04, Table X) [ka] (Example X.04, Table X) A solution of 2-[(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (0.050 g, 1.0, 0.14 mmol) in DMF (1.4 mL) was treated with oxetane-3-carboxylic acid (0.019 g, 1.2, 0.17 mmol), N,N-diisopropylethylamine (0.048 g, 0.064 mL, 0.37 mmol) and HATU (0.082 g, 0.21 mmol). The resulting light brown solution was stirred at room temperature for 4 hours. After this time, the reaction mixture was quenched with saturated aqueous sodium bicarbonate and diluted with water. It was then extracted twice with ethyl acetate and the combined organic layers were washed with brine and anhydrous Na 2 SO 4 The crude product was purified by reverse phase chromatography eluting with acetonitrile / water to give the title compound as a beige powder. 1 H NMR (400 MHz, CDCl 3 )δ ppm 0.97(s,3H)1.14(s,3H)1.50-1.65(m,2H)1.65-1.81(m,1H)2.19-2.34(m,1H)2.84(s,3H)3.8 6-4.01(m,1H)4.13-4.26(m,1H)4.51-4.65(m,2H)4.92-5.06(m,2H)6.82(s,2H)6.91-7.08(br s,1H); LC-MS (Method A): 437[M+H], Rt: 1.05 min.

[0225] Example P4: Preparation of 2-[(2,6-difluoro-4-pyridyl)-(tetrahydropyran-4-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (Example X.11, Table X) [ka] (Example X.11, Table X) A solution of tetrahydro-2h-pyran-4-carboxylic acid (6.282 g, 46.82 mmol) in acetonitrile (86 mL) was treated with 1-propanephosphonic anhydride (99.32 g, 93.00 mL, 156.1 mmol), N,N-diisopropylethylamine (40.75 g, 54.6 mL, 10.00, 312.1 mmol), and 2-[(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (11 g, 1.000, 31.21 mmol) was added to give a brown solution. The reaction mixture was stirred at 50° C. under argon for 16 hours. After completion of the reaction, the reaction mixture was allowed to cool and slowly added to saturated aqueous sodium bicarbonate at 0° C. The reaction mixture was then extracted with ethyl acetate (×3) and the combined organic extracts were washed once with brine and anhydrous Na 2 SO 4 Drying at 40° C., filtering and concentrating in vacuo gave 15.88 g of a light brown powder. Flash chromatography eluting with ethyl acetate / cyclohexane gave the title product as a white powder. 1 H NMR (400 MHz, CDCl 3 )δ ppm 0.93(s,3H)1.13(s,3H)1.50-1.76(m,5H)1.97-2.09(m,2H)2.25(dtd,J=10.90,8.08,8.08,2.72Hz,1H)2.60(tt,J=11.26,3. 81Hz,1H)2.81(s,3H)3.29(tt,J=11.90,1.91Hz,2H)4.01(dt,J=11.63,2.18Hz,2H)4.18(q,J=8.60Hz,1H)6.89(s,2H)6.99(br d,J=9.08Hz,1H); LC-MS (Method A): 465[M+H], Rt: 1.11 min.

[0226] If necessary, enantiomerically pure final compounds may be obtained from racemic material, as appropriate, by standard physical separation techniques such as reverse-phase chiral chromatography or through stereoselective synthetic techniques (e.g., by using chiral starting materials).

[0227] Further examples of compounds of formula (I) that have been synthesised are shown in Table T1.

[0228] [Table 5-1] [Table 5-2] [Table 5-3]

[0229] Biological Examples Example A1: Alternaria solani / Tomato / Leaf disc (summer blight) Tomato leaf discs (cv. Baby) are placed on agar in multi-well plates (24-well type) and sprayed with the formulated test compounds diluted in water. The leaves are inoculated with a fungal spore suspension 2 days after application. The inoculated leaves are incubated in a climate cabinet under a 12 / 12 h (light / dark) light regime, at 23°C / 21°C (day / night) and 80% relative humidity, and when an appropriate level of disease damage has developed on untreated test leaf discs (5-7 days after application), the efficacy of the compounds is evaluated as the percentage of disease control compared to untreated ones. The following compounds provided at least 80% control of Alternaria solani at 200 ppm when compared to untreated controls which showed widespread disease development under identical conditions: X.01, X.02, X.03, X.04, X.05, X.06, X.09, X.10 and X.11.

[0230] Example A2: Botryotinia fuckeliana (Botrytis cinerea) / Liquid culture (grey mold) Fungal conidia stored at low temperature are mixed directly into nutrient broth (Vogel broth). A (DMSO) solution of the test compound is placed in a microtiter plate (96-well format) followed by the addition of the nutrient broth containing the fungal spores. The test plates are incubated at 24°C and growth inhibition is measured photometrically 3-4 days after application. The following compounds provided at least 80% control of Botryotinia fuckeliana at 20 ppm under identical conditions when compared to untreated controls which showed widespread disease development: X.02 and X.04.

[0231] Example A3: Glomerella lagenarium (Colletotrichum lagenarium) / Liquid Culture (Anthracnose) Fungal conidia stored at low temperature are mixed directly into nutrient broth (PDB potato dextrose broth). A (DMSO) solution of the test compound is placed in a microtiter plate (96-well format) followed by the addition of the nutrient broth containing the fungal spores. The test plates are incubated at 24°C and growth inhibition is measured photometrically 3-4 days after application. The following compounds provided at least 80% control of Glomerella lagenarium at 20 ppm under identical conditions when compared to untreated controls which showed widespread disease development: X.01, X.02, X.03, X.04, X.06, X.09, X.10 and X.11.

[0232] Example A4: Blumeria graminis f.sp. tritici (Erysiphe graminis f.sp. tritici) / Wheat / Leaf-plate prevention (Wheat powdery mildew) Wheat leaf segments (cv. Kanzler) are placed on agar in multi-well plates (24-well format) and sprayed with the formulated test compounds diluted in water. One day after application, the leaf segments are inoculated with powdery mildew-infected plants by shaking them over the test plates. The inoculated leaf segments are incubated in a climatic chamber at 20°C and 60% relative humidity, under a light regime of 24 hours darkness followed by 12 hours light / 12 hours darkness, and when an appropriate level of disease damage has developed on the untreated test leaf segments (6-8 days after application), the efficacy of the compounds is evaluated as the percentage of disease control compared to the untreated ones. The following compounds provided at least 80% control of Blumeria graminis f.sp. tritici at 200 ppm when compared to untreated controls which showed widespread disease development under identical conditions: X.01, X.02, X.03, X.04, X.05, X.06, X.07, X.08, X.09, X.10 and X.11.

[0233] Example A5: Phaeosphaeria nodorum (Septoria nodorum) / Wheat / Leaf blight prevention (Septoria nodorum) Wheat leaf segments (cv. Kanzler) are placed on agar in multi-well plates (24-well format) and sprayed with the formulated test compounds diluted in water. The leaf segments are inoculated with a fungal spore suspension 2 days after application. The inoculated test leaf segments are incubated in a climate cabinet at 20°C and 75% relative humidity under a 12-hour light / 12-hour dark light regime, and when an appropriate level of disease damage occurs on the untreated test leaf segments (5-7 days after application), the efficacy of the compounds is evaluated as the perce...

Claims

1. A fungicidal composition comprising a mixture of components (A) and (B) as active ingredients, wherein component (A) is a compound represented by formula (I): 【Chemistry 1】 (In the formula, A is C—H or N; R 1 is C 1 ~C 4 Alkoxy C 1 ~C 2 Alkyl, C 1 ~C 6 Alkylsulfanyl C 1 ~C 6 Alkyl, C 1 ~C 6 Alkylsulfinyl C 1 ~C 6 Alkyl, C 1 ~C 6 Alkylsulfonyl C 1 ~C 6 alkyl or heterocyclyl, wherein said heterocyclyl moiety is a 4-, 5-, or 6-membered non-aromatic monocyclic ring containing 1, 2, or 3 heteroatoms independently selected from nitrogen, oxygen, and sulfur; R 2 is hydrogen or halogen; R 3 is C 1 ~C 8 is alkyl; R 4 , R 5 , R 6 are each independently hydrogen or C 1 ~C 4 is alkyl; R 7 is hydrogen, C 1 ~C 4 Alkyl, C 1 ~C 6 Alkoxycarbonyl C 1 ~C 4 Alkyl, C 1 ~C 6 Alkoxycarbonyl or C 1 ~C 6 is alkoxy; R 8 is hydrogen, C 1 ~C 6 Alkoxy C 1 ~C 6 Alkylcarbonyl, C 1 ~C 6 Alkylsulfanyl C 1 ~C 6 Alkylcarbonyl, C 1 ~C 6 Alkylsulfinyl C 1 ~C 6 Alkylcarbonyl, C 1 ~C 6 Alkylsulfonyl C 1 ~C 6 alkylcarbonyl or heterocyclylcarbonyl, wherein the heterocyclyl moiety is a 4-, 5-, or 6-membered non-aromatic monocyclic ring containing 1, 2, or 3 heteroatoms independently selected from nitrogen, oxygen, and sulfur. or a salt or N-oxide thereof; and Component (B) is azoxystrobin, trifloxystrobin, pyraclostrobin, picoxystrobin, cumoxystrobin, methyltetraprole, cyproconazole, tebuconazole, difenoconazole, hexaconazole, propiconazole, fenhexamid, prothioconazole, mefentrifluconazole, prochloraz, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflucipram, bixafen, penthiopyrad, Inpirfluxam, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, trinexapac-ethyl, fosetylaluminum, chlorothalonil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tebufloquine, tolprocarb, tricyclazole, pyroquilon, cyflufenamid, metrafenone, N'-[2-chloro-4-( 2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline- 3-Carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2 -dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy] methyl (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate, methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3 -methoxy-prop-2-enoate, methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]-3- A fungicidal composition comprising a compound selected from the group consisting of methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, TAEGRO® (i.e., Bacillus amyloliquefaciens strain FZB24), Timorex Gold®, and methallylpicoxamide.

2. Component (A) is 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-N-(tetrahydrofuran-3-carbonyl)thiazole-4-carboxamide (compound X.01); 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-2-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.02); 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.03); 2-[(2,6-difluoro-4-pyridyl)-(oxetane-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.04); 2-[2-tert-butoxypropanoyl-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.05); 2-[(2,6-difluoro-4-pyridyl)-(2-isopropoxypropanoyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.06); 2-[(2-tert-butoxyacetyl)-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.07); 2-[(2,6-difluoro-4-pyridyl)-(2-isopropoxyacetyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.08); 2-[(2,6-difluoro-4-pyridyl)-(2-methoxypropanoyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.09); 2-[(2,6-difluoro-4-pyridyl)-(2-methylsulfonylpropanoyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.10); and 2-[(2,6-Difluoro-4-pyridyl)-(tetrahydropyran-4-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.11) 2. The fungicidal composition of claim 1, wherein the compound is selected from the group consisting of:

3. Component (A) is 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-2-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.02); 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.03); 2-[(2,6-difluoro-4-pyridyl)-(oxetane-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.04); 2-[2-tert-butoxypropanoyl-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.05); 2-[(2-tert-butoxyacetyl)-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.07); 2-[(2,6-difluoro-4-pyridyl)-(2-methoxypropanoyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.09); and 2-[(2,6-Difluoro-4-pyridyl)-(tetrahydropyran-4-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.11) 2. The fungicidal composition of claim 1, wherein the compound is selected from the group consisting of:

4. Component (A) is 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-2-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.02); 2-[(2,6-difluoro-4-pyridyl)-(tetrahydrofuran-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.03); 2-[(2,6-difluoro-4-pyridyl)-(oxetane-3-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.04); and 2-[(2,6-Difluoro-4-pyridyl)-(tetrahydropyran-4-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.11) 2. The fungicidal composition of claim 1, wherein the compound is selected from the group consisting of:

5. Component (B) is azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, acibenzolar-S-methyl, chlorota Ronil, mancozeb, mandipropamide, oxathiapiproline, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, cyflufenamid, metrafenone, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine Muamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro -3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine N-isopropyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4 -oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3 -yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-meth methyl (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate, methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate ate, methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z) 2. The fungicidal composition of claim 1, wherein the compound is selected from the group consisting of methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, bixafen, fosetyl aluminum, TAEGRO®, tea tree oil (extract of the tea tree plant Melaleuca alternifolia (commercially available as Timorex Gold®, a broad-spectrum botanical biofungicide)), and methallyl picoxamide.

6. Component (B) is selected from the group consisting of azoxystrobin, trifloxystrobin, methyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isofulcipram, isofetamide, pyrapropoin, fluindapyr, fenpicoxamide, florylpicoxamide, chlorothalonil, mancozeb, mandipropamide, oxathiapiprolin, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, N-(1-benzyl-1,3-dimethyl- 2. The disinfectant composition of claim 1, wherein the compound is selected from the group consisting of N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline.

7. 2. The fungicidal composition of claim 1, wherein the weight ratio of component (A) to component (B) is from 100:1 to 1:

100.

8. 2. The fungicidal composition of claim 1, wherein the weight ratio of component (A) to component (B) is from 20:1 to 1:

40.

9. 2. The fungicidal composition of claim 1, wherein the weight ratio of component (A) to component (B) is from 12:1 to 1:

25.

10. 2. The fungicidal composition of claim 1, wherein the weight ratio of component (A) to component (B) is from 5:1 to 1:

15.

11. 2. The fungicidal composition of claim 1, wherein the weight ratio of component (A) to component (B) is from 2:1 to 1:

5.

12. Etridiazole, fluazinam, benzovindiflupyr, pydiflumetofen, benalaxyl, benalaxyl-M (chiralaxyl), furalaxyl, metalaxyl, metalaxyl-M (mefenoxam), dodisin, N'-(2,5-dimethyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidine, N'-[4-(4,5-dichloro-thiazol-2-yloxy)-2,5-dimethyl-phenyl]-N-ethyl-N-methyl- Formamidine, N'-[4-[[3-[(4-chlorophenyl)methyl]-1,2,4-thiadiazol-5-yl]oxy]-2,5-dimethyl-phenyl]-N-ethyl-N-methyl-formamidine, ethirimol, 3'-chloro-2-methoxy-N-[(3RS)-tetrahydro-2-oxofuran-3-yl]aceto-2',6'-xylidide (clozylacon), cyprodinil, mepanipyrim, pyrimethanil, dithianon, aureofungin , blasticidin-S, biphenyl, chloroneb, dicloran, hexachlorobenzene, quintozene, tecnazene (TCNB), tolclofos-methyl, metrafenone, 2,6-dichloro-N-(4-trifluoromethylbenzyl)-benzamide, fluopicolide (flupicolide), thioximide, flusulfamide, benomyl, carbendazim, carbendazim chlorhydrate, chlorphenazole, fuberidazole, thiabendazole, thiazole ofanate-methyl, benthiavalicarb, clobenthiazone, probenazole, acibenzolar, bethoxadin, pyriophenone (IKF-309), acibenzolar-S-methyl, pyribencarb (KIF-7767), butylamine, 3-iodo-2-propynyl n-butylcarbamate (IPBC), picabutrazox, polycarbamate, propamocarb, tolprocarb, 3-(difluoromethyl)-N-(7-fluoro-1,1,3,3-tetramethyl-indan-4-yl)-1-methyl-pyrazole-4-carboxamide, diclocymet, N-[(5-chloro-2-isopropyl-phenyl)methyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-pyrazole-4-carboxamide, N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-[(2-isopropylphenyl)methyl]-1-methyl-pyrazole-4-carboxamide, carpropamid, chlorothalonil, flumorph, oxine-copper, cymoxanil, fenamacril, cyazofamid, fluthianil, thiciophen, chlozolinate, iprodione, procymidone, vinclozolin, bupirimate, dinoctone, dinopenton, dinobuton, dinocap, meptyldinocap, diphenyl Amine, phosdaifen, 2,6-dimethyl-[1,4]dithiino[2,3-c:5,6-c']dipyrrole-1,3,5,7(2H,6H)-tetraone, azithiram, ethem, ferbam, mancozeb, maneb, metham, metiram (polyram), metiram-zinc, nabam, propineb, thiram, bapam (metam sodium), zineb, ziram, dithioether, isoprothiolane, etham Taboxam, fosetyl, fosetyl-aluminum (fosetyl-al), methyl bromide, methyl iodide, methyl isothiocyanate, cyclafuramide, fenfuram, validamycin, streptomycin, (2RS)-2-bromo-2-(bromomethyl)glutaronitrile (bromothalonil), dodine, dogudine, guazatine, iminoctadine, iminoctadine triacetate, 2,4-D, 2,4-DB, kasugamycin, dimethirimol, fenhexamid, hymexazole, hydroxyisoxazole, imazalil, imazalil sulfate, oxpoconazole, pefurazoate, prochloraz, triflumizole, fenamidone, Bordeaux mixture, calcium polysulfide, copper acetate, copper carbonate, copper hydroxide, copper naphthenate, copper oleate, copper oxychloride, copper oxyquinolate, copper silicate, copper sulfate, copper thalate, cuprous oxide, sulfur, carbaryl, phthalide, Jingyuenzuo (Jun Si) Qi), oxathiapiproline, fluoroimide, mandipropamid, KSF-1002, benzam- ph, dimethomorph, fenpropimorph, tridemorph, dodemorph, diethofencarb, fentin acetate, fentin hydroxide, carboxin, oxycarboxin, drazoxolone, famoxadone, m-phenylphenol, p-phenylphenol, tribromophenol (TBP), 2-[2-[(7,8-difluoro-2-methyl-3-quinolyl)oxy]-6-fluoro-phenyl]propan-2-ol, 2-[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolyl)oxy]phenyl]propan-2-ol, cyflufenamid, ofurase, oxadixyl, flutolanil, mepronil, isofetamide, fenpiclonil, fludioxonil, pencycuron, edifenphos, iproben Phos, pyrazophos, phosphorous acid, teclofuram, captafol, captan, ditalimfos, triforine, fenpropidin, piperalin, osthole, 1-methylcyclopropene, 4-CPA, chlormequat, clofencet, dichloroprop, dimethipin, endothall, ethephon, flumetralin, forchlorfenuron, gibberellic acid, gibberellin, hymexazol, maleic hydrazide, mepicor , naphthaleneacetamide, paclobutrazol, prohexadione, prohexadione-calcium, thidiazuron, tribufos (tributyl phosphorotrithioate), trinexapac, uniconazole, α-naphthaleneacetic acid, polyoxin D (polyoxymethylene), BLAD, chitosan, fenoxanil, folpet, 3-(difluoromethyl)-N-methoxy-1-methyl-N-[1-methyl-2-(2,4,6-trichlorophenyl)ethyl]pyrazole-4-carboxamide, bixafen, fluxapyroxad, furametpyr, isopyrazam, penflufen, penthiopyrad, sedaxane, fenpyrazamine, diclomedine, pyrifenox, boscalid, fluopyram, diflumetrim, fenarimol, 5-fluoro-2-(p-tolylmethoxy)pyrimidin-4-amine, ferimzone, dimethaclon (dimethaclon), pyroquilon, proquinazide, ethoxyquin, quinoxyfen, 4,4,5-trifluoro-3,3-dimethyl- 1-(3-quinolyl)isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(3-quinolyl)isoquinoline, 5-fluoro-3,3,4,4-tetramethyl-1-(3-quinolyl)isoquinoline, 9-fluoro-2,2-dimethyl-5-(3-quinolyl)-3H-1,4-benzoxazepine, tebufloquine, oxolinic acid, quinomethionate (oxythioquinox, quinoxymethionate), spiroxamine, (E)-N-methyl-2-[2-(2,5-dimethylphenoxymethyl)phenyl]-2-methoxy-iminoacetamine , azoxystrobin, cumoxystrobin, dimoxystrobin, enestrobulin, pyriostrobin, fenamistrobin, flufenoxystrobin, fluoxastrobin, kresoxim-methyl, mandestrobin, metaminostrobin, metominostrobin, oryzastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxystrobin, triclopyricarb, trifloxystrobin, amisulbrom, dichlofluanid, tolylfluanid, but-3-ynyl N-[6-[[(Z)-[(1 -methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate, dazomet, isotianil, tiadinil, thifluzamide, benzazole (TCMTB), silthiofam, zoxamide, anilazine, tricyclazole, (rac)-cis-1-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-yl)-cycloheptanol (Fangjunzuo), 1-(5-bromo-2-pyridyl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1,2,4-triazol-1-yl)propan-2-ol, 2-(1-tert-butyl)-1-(2-chlorophenyl)-3-(1,2,4-triazol-1-yl)-propan-2-ol (TCDP), (N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine), azaconazole, bitertanol (viloxazole), bromuconazole, climbazole, cyproconazo dimethicone, difenoconazole, dimethicone, diniconazole-M, epoxiconazole, etaconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, penconazole, propiconazole, prothioconazole, mefentrifluconazole, simeconazole, tebuconazole, tetraconazole, triadimefol phenanthrene, triadimenol, triazoxide, triticonazole, 2-[[(1R,5S)-5-[(4-fluorophenyl)methyl]-1-hydroxy-2,2-dimethyl-cyclopentyl]methyl]-4H-1,2,4-triazole-3-thione, 2-[[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl]-4H-1,2,4-triazole-3-thione, ametoctrazine (imidium), iprovalicarb, a fungicide selected from valifenalate, 2-benzyl-4-chlorophenol (chlorophen), allyl alcohol, azafenidin, benzalkonium chloride, chloropicrin, cresol, dalacid, dichlorophen (dichlorophen), difenzoquat, dipyrithione, N-(2-p-chlorobenzoylethyl)-hexaminium chloride, NNF-0721, octhilinone, oxasulfuron, tea tree oil (extract of the tea tree plant Melaleuca alternifolia (commercially available as Timorex Gold®, a broad-spectrum botanical biofungicide)), propamidine, and propionic acid; or Abamectin, acephate, acetamiprid, amidoflumet (S-1955), avermectin, azadirachtin, azinphos-methyl, bifenthrin, bifenazate, buprofezin, carbofuran, cartap, chlorantraniliprole (DPX-E2Y45), chlorfenapyr, chlorfluazuron, chlorpyrifos, chlorpyrifos-methyl, chromafenozide, clothianidin, cyflumetofen, cyfluthrin, beta-cy Fluthrin, cyhalothrin, lambda-cyhalothrin, cypermethrin, cyromazine, deltamethrin, diafenthiuron, diazinon, dieldrin, diflubenzuron, dimefluthrin, dimethoate, dinotefuran, diofenolan, emamectin, endosulfan, esfenvalerate, ethiprole, fenothiocarb, fenoxycarb, fenpropathrin, fenvalerate, fipronil, flonicamid, flubendiamide, Flucythrinate, tau-fluvalinate, flufenerim (UR-50701), flufenoxuron, fonofos, halofenozide, hexaflumuron, hydramethylnon, imidacloprid, indoxacarb, isofenphos, lufenuron, malathion, metaflumizone, metaldehyde, methamidophos, methidathion, methomyl, methoprene, methoxychlor, metofluthrin, monocrotophos, methoxyfenozide, nitenpyram, nichi an insecticide selected from azine, novaluron, noviflumuron (XDE-007), oxamyl, parathion, parathion-methyl, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, profenofos, profluthrin, pymetrozine, pyrafluprole, pyrethrins, pyridalyl, pyrifluquinazon, pyriprole, pyriproxyfen, rotenone, ryanodine, spinetoram, spinosad, spirodiclofen, spiromesifen (BSN 2060), spirotetramat, sulprofos, tebufenozide, teflubenzuron, terftrin, terbufos, tetrachlorvinphos, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tralomethrin, triazamate, trichlorfon, and triflumuron; or a bactericide selected from streptomycin; or an acaricide selected from amitraz, quinomethionate, chlorobenzilate, cyenopyrafen, cyhexatin, dicofol, dienochlor, etoxazole, fenazaquin, fenbutatin oxide, fenpropathrin, fenpyroximate, hexythiazox, propargite, pyridaben, and tebufenpyrad; or a biological agent selected from Bacillus thuringiensis, Bacillus thuringiensis delta-endotoxin, baculovirus, and entomopathogenic bacteria, viruses, and fungi; 10. The fungicidal composition of claim 1, further comprising one or more additional pesticides selected from the group consisting of:

13. 10. The fungicidal composition of claim 1 further comprising an agriculturally acceptable carrier and optionally a surfactant and / or formulation aid.

14. A method for controlling or preventing phytopathogenic diseases, in particular phytopathogenic fungi, in useful plants or their propagation material, which comprises applying to said useful plants, their habitat or their propagation material a fungicidal composition according to any one of claims 1 to 12.

15. 15. The method of claim 14, wherein components (A) and (B) of the composition are applied in a sequential manner.

Images